<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">mBio</journal-id><journal-id journal-id-type="iso-abbrev">mBio</journal-id><journal-id journal-id-type="hwp">mbio</journal-id><journal-id journal-id-type="pmc">mbio</journal-id><journal-id journal-id-type="publisher-id">mBio</journal-id><journal-title-group><journal-title>mBio</journal-title></journal-title-group><issn pub-type="epub">2150-7511</issn><publisher><publisher-name>American Society for Microbiology</publisher-name><publisher-loc>1752 N St., N.W., Washington, DC</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6692506</article-id><article-id pub-id-type="pmid">31409675</article-id><article-id pub-id-type="publisher-id">mBio01230-19</article-id><article-id pub-id-type="doi">10.1128/mBio.01230-19</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="overline"><subject>Applied and Environmental Science</subject></subj-group><subj-group subj-group-type="editorial-class"><subject>Editor's Pick</subject></subj-group></article-categories><title-group><article-title>A Single Biosynthetic Gene Cluster Is Responsible for the Production of Bagremycin Antibiotics and Ferroverdin Iron Chelators</article-title><alt-title alt-title-type="running-head">One Cluster for Bagremycin and Ferroverdin Production</alt-title><alt-title alt-title-type="short-authors">Martinet et al.</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Martinet</surname><given-names>Lo&#x000ef;c</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Na&#x000f4;m&#x000e9;</surname><given-names>Aymeric</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Deflandre</surname><given-names>Benoit</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Maciejewska</surname><given-names>Marta</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Tellatin</surname><given-names>D&#x000e9;borah</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Tenconi</surname><given-names>Elodie</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Smargiasso</surname><given-names>Nicolas</given-names></name><xref ref-type="aff" rid="aff2"><sup>b</sup></xref></contrib><contrib contrib-type="author"><name><surname>de Pauw</surname><given-names>Edwin</given-names></name><xref ref-type="aff" rid="aff2"><sup>b</sup></xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-0341-1561</contrib-id><name><surname>van Wezel</surname><given-names>Gilles P.</given-names></name><xref ref-type="aff" rid="aff3"><sup>c</sup></xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-4022-7325</contrib-id><name><surname>Rigali</surname><given-names>S&#x000e9;bastien</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><aff id="aff1"><label>a</label><addr-line>InBioS&#x02014;Centre for Protein Engineering, Institut de Chimie B6a, University of Li&#x000e8;ge, Li&#x000e8;ge, Belgium</addr-line></aff><aff id="aff2"><label>b</label><addr-line>MolSys Research Unit, Mass Spectrometry Laboratory, University of Li&#x000e8;ge, Li&#x000e8;ge, Belgium</addr-line></aff><aff id="aff3"><label>c</label><addr-line>Molecular Biotechnology, Institute of Biology, Leiden University, Leiden, The Netherlands</addr-line></aff></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Wright</surname><given-names>Gerard D.</given-names></name><role>Editor</role><aff>McMaster University</aff></contrib></contrib-group><author-notes><corresp id="cor1">
Address correspondence to S&#x000e9;bastien Rigali, <email>srigali@uliege.be</email>.</corresp></author-notes><pub-date pub-type="epub"><day>13</day><month>8</month><year>2019</year></pub-date><pub-date pub-type="collection"><season>Jul-Aug</season><year>2019</year></pub-date><volume>10</volume><issue>4</issue><elocation-id>e01230-19</elocation-id><history><date date-type="received"><day>13</day><month>5</month><year>2019</year></date><date date-type="accepted"><day>12</day><month>7</month><year>2019</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2019 Martinet et al.</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>Martinet et al.</copyright-holder><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="mBio.01230-19.pdf"/><abstract abstract-type="precis"><p>Access to whole-genome sequences has exposed the general incidence of the so-called cryptic biosynthetic gene clusters (BGCs), thereby renewing their interest for natural product discovery. As a consequence, genome mining is the often first approach implemented to assess the potential of a microorganism for producing novel bioactive metabolites. By revealing a new level of complexity of natural product biosynthesis, we further illustrate the difficulty of estimation of the panel of molecules associated with a BGC based on genomic information alone. Indeed, we found that the same gene cluster is responsible for the production of compounds which differ in terms of structure and bioactivity. The production of these different compounds responds to different environmental triggers, which suggests that multiplication of culture conditions is essential for revealing the entire panel of molecules made by a single BGC.</p></abstract><abstract><title>ABSTRACT</title><p>Biosynthetic gene clusters (BGCs) are organized groups of genes involved in the production of specialized metabolites. Typically, one BGC is responsible for the production of one or several similar compounds with bioactivities that usually only vary in terms of strength and/or specificity. Here we show that the previously described ferroverdins and bagremycins, which are families of metabolites with different bioactivities, are produced from the same BGC, whereby the fate of the biosynthetic pathway depends on iron availability. Under conditions of iron depletion, the monomeric bagremycins are formed, representing amino-aromatic antibiotics resulting from the condensation of 3-amino-4-hydroxybenzoic acid with <italic>p</italic>-vinylphenol. Conversely, when iron is abundantly available, the biosynthetic pathway additionally produces a molecule based on <italic>p</italic>-vinylphenyl-3-nitroso-4-hydroxybenzoate, which complexes iron to form the trimeric ferroverdins that have anticholesterol activity. Thus, our work shows a unique exception to the concept that BGCs should only produce a single family of molecules with one type of bioactivity and that in fact different bioactive molecules may be produced depending on the environmental conditions.</p></abstract><kwd-group><title>KEYWORDS</title><kwd><italic>Streptomyces</italic></kwd><kwd>genome analysis</kwd><kwd>iron regulation</kwd><kwd>natural antimicrobial products</kwd><kwd>secondary metabolism</kwd></kwd-group><funding-group><award-group id="award1"><funding-source><institution-wrap><institution>Netherlands Organization for Scientific Research</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>van Wezel</surname><given-names>Gilles</given-names></name></principal-award-recipient></award-group><award-group id="award2"><funding-source><institution-wrap><institution>Region Wallonne</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Rigali</surname><given-names>S&#x000e9;bastien</given-names></name></principal-award-recipient><principal-award-recipient><name><surname>Na&#x000f4;m&#x000e9;</surname><given-names>Aymeric</given-names></name></principal-award-recipient></award-group><award-group id="award3"><funding-source><institution-wrap><institution>Fonds De La Recherche Scientifique - FNRS (FNRS)</institution><institution-id>https://doi.org/10.13039/501100002661</institution-id></institution-wrap></funding-source><principal-award-recipient><name><surname>Rigali</surname><given-names>S&#x000e9;bastien</given-names></name></principal-award-recipient><principal-award-recipient><name><surname>Deflandre</surname><given-names>Benoit</given-names></name></principal-award-recipient><principal-award-recipient><name><surname>Martinet</surname><given-names>Lo&#x000ef;c</given-names></name></principal-award-recipient></award-group></funding-group><counts><count count="3" count-type="supplementary-material"/><fig-count count="8"/><table-count count="2"/><equation-count count="0"/><ref-count count="45"/><page-count count="15"/><word-count count="8640"/></counts><custom-meta-group><custom-meta><meta-name>cover-date</meta-name><meta-value>July/August 2019</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="s1"><title>INTRODUCTION</title><p>Specialized metabolites are natural products (NPs) that play essential roles by helping the producing strain to cope with various stresses, are used as weapons to outcompete neighboring commensals, or are required at particular physiological or developmental stages (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B2" ref-type="bibr">2</xref>). Besides their role in improving the fitness of microorganisms in their habitat, among others, molecules emanating from the so-called secondary metabolism are of foremost therapeutic and agroindustrial importance (<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B4" ref-type="bibr">4</xref>). These bioactive compounds are produced by a form of machinery encoded by a group of genes&#x02014;a biosynthetic gene cluster (BGC)&#x02014;that, in addition to biosynthetic genes, typically includes genes for expression control, self-resistance, and export (<xref rid="B4" ref-type="bibr">4</xref><xref ref-type="bibr" rid="B5">&#x02013;</xref><xref rid="B6" ref-type="bibr">6</xref>).</p><p>Genome sequencing of secondary-metabolite-producing microorganisms has revealed an enormous potential to increase the known chemical space (<xref rid="B5" ref-type="bibr">5</xref>), with the promise of new leads in human therapies or for sustainable agriculture. One of the drivers of the renewed interest in NPs was the discovery of so-called cryptic BGCs that are silent under routine laboratory conditions and may therefore specify molecules that had so far been missed during pharmaceutical screening (<xref rid="B7" ref-type="bibr">7</xref><xref ref-type="bibr" rid="B8">&#x02013;</xref><xref rid="B9" ref-type="bibr">9</xref>). An approach that is rapidly gaining momentum is that of expressing cryptic BGCs in a heterologous chassis strain or superhost and exchanging promoter elements within the BGC with those that are expected to result in high levels of expression under laboratory conditions. However, there are several problems associated with this approach. First, it is still difficult to effectively apply it through high-throughput strategies, and it is hard to establish the promise of the activity of a certain BGC on the basis of the DNA sequence alone (<xref rid="B10" ref-type="bibr">10</xref>). Second, examples of NPs that are produced from multiple BGCs, or by strains in coculture, are accumulating (<xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B12" ref-type="bibr">12</xref>). Alternatively, a single BGC may also be responsible for the production of many (up to over 100) structurally related molecules that differ in terms of their activity (<xref rid="B13" ref-type="bibr">13</xref><xref ref-type="bibr" rid="B14">&#x02013;</xref><xref rid="B15" ref-type="bibr">15</xref>), or BGCs can be associated into &#x0201c;superclusters&#x0201d; that function to produce two or more similar molecules (<xref rid="B16" ref-type="bibr">16</xref>, <xref rid="B17" ref-type="bibr">17</xref>). Thus, to optimally exploit the chemical space of NPs, we need to understand the connection between the genomic diversity and the chemical diversity of their biosynthetic pathways.</p><p>Here we provide an example that further illustrates the complexity of analyses designed to estimate the metabolome profile as well as the industrial potential of a microorganism based on the genomic information alone. Our work revealed that the ferrous compounds called ferroverdins (<xref ref-type="fig" rid="fig1">Fig.&#x000a0;1</xref>, structures 1 to 3 [<xref rid="B18" ref-type="bibr">18</xref><xref ref-type="bibr" rid="B19">&#x02013;</xref><xref rid="B20" ref-type="bibr">20</xref>]), which are inhibitors of cholesterylester transfer protein (CETP) and thus are molecules potentially able to reduce the risk of atherosclerosis (<xref rid="B21" ref-type="bibr">21</xref>), and the antibiotics called bagremycins (<xref ref-type="fig" rid="fig1">Fig.&#x000a0;1</xref>, structures 4 to 9 [<xref rid="B22" ref-type="bibr">22</xref><xref ref-type="bibr" rid="B23">&#x02013;</xref><xref rid="B24" ref-type="bibr">24</xref>]) are synthesized from the same BGC. These molecules not only have completely different biological functions, but their biosynthesis also requires different environmental triggers. These findings challenge the concept that a given BGC is associated with production of similar compounds in terms of building blocks, structure, bioactivity, and conditions for production.</p><fig id="fig1" orientation="portrait" position="float"><label>FIG&#x000a0;1</label><caption><p>Structures of ferroverdins and bagremycins produced by <named-content content-type="genus-species">S. lunaelactis</named-content> strains. The top line displays the structures of ferroverdins (structures 1 to 3) and the bottom line the structures of bagremycins (structures 4 to 9), including the molecular formula of each. The monomer specific to ferroverdin B (hydroxy-<italic>p</italic>-vinylphenyl-3,4-NHBA) and the monomer specific to ferroverdin C (and carboxy-<italic>p</italic>-vinylphenyl-3,4-NHBA) are shaded in gray.</p></caption><graphic xlink:href="mBio.01230-19-f0001"/></fig></sec><sec sec-type="results" id="s2"><title>RESULTS</title><sec id="s2.1"><title><named-content content-type="genus-species">Streptomyces lunaelactis</named-content> produces ferroverdins and bagremycins.</title><p>Strains of <named-content content-type="genus-species">Streptomyces lunaelactis</named-content>, including type strain MM109<sup>T</sup>, were previously isolated from cave moonmilk deposits (<xref rid="B25" ref-type="bibr">25</xref><xref ref-type="bibr" rid="B26">&#x02013;</xref><xref rid="B27" ref-type="bibr">27</xref>). Strain MM109<sup>T</sup> produces a green pigment whose presence was attributed to the biosynthesis of ferroverdin A (<xref rid="B25" ref-type="bibr">25</xref>), a homotrimer of <italic>p</italic>-vinylphenyl-3-nitroso-4-hydroxybenzoate (<italic>p</italic>-vinylphenyl-3,4-NHBA) complexed with one ferrous ion (<xref rid="B18" ref-type="bibr">18</xref>, <xref rid="B19" ref-type="bibr">19</xref>). To assess the metabolomic response of <named-content content-type="genus-species">S. lunaelactis</named-content>, including the conditions under which ferroverdin A is produced, strain MM109<sup>T</sup> was grown under different culture conditions. For this assessment, disc diffusion assays were performed in the presence of a range of different metals.</p><p>The results revealed that only the addition of the ferric iron salt FeCl<sub>3</sub> (as well as the addition of ferrous iron FeSO<sub>4</sub>; data not shown) triggered production of the green pigmented ferroverdin A by <named-content content-type="genus-species">S. lunaelactis</named-content> MM109<sup>T</sup> (<xref ref-type="fig" rid="fig2">Fig.&#x000a0;2A</xref>). Production of ferroverdin A (structure 1 in <xref ref-type="fig" rid="fig1">Fig.&#x000a0;1</xref>; see also <xref ref-type="fig" rid="fig2">Fig.&#x000a0;2C</xref>) was triggered at a FeCl<sub>3</sub> concentration as low as 0.01&#x02009;mM (<xref ref-type="fig" rid="fig2">Fig.&#x000a0;2B</xref>). Ultraperformance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) analysis of extracts of strain MM109<sup>T</sup> identified an ion peak of <italic>m/z</italic> 876.11 [M<sup>-</sup>], corresponding to ferroverdin B (structure 2 in <xref ref-type="fig" rid="fig1">Fig.&#x000a0;1</xref>), and a distinct ion peak of <italic>m/z</italic> 904.11 [M<sup>-</sup>] corresponding to ferroverdin C (structure 3 in <xref ref-type="fig" rid="fig1">Fig.&#x000a0;1</xref>). Ferroverdin B and ferroverdin C heterotrimers differ from ferroverdin A in only one of the three ligands used to complex ferrous iron, namely, hydroxy-<italic>p</italic>-vinylphenyl-3,4-NHBA for ferroverdin B and carboxy-<italic>p</italic>-vinylphenyl-3,4-NHBA for ferroverdin C (<xref ref-type="fig" rid="fig1">Fig.&#x000a0;1</xref>).</p><fig id="fig2" orientation="portrait" position="float"><label>FIG&#x000a0;2</label><caption><p>Production of ferroverdins by <named-content content-type="genus-species">S. lunaelactis</named-content> MM109<sup>T</sup>. (A) Paper disc diffusion assays with various metal salts (1&#x02009;mM). Note that FeCl<sub>3</sub> was the only metal salt able to trigger the green pigmentation of the mycelium of <named-content content-type="genus-species">S. lunaelactis</named-content> MM109<sup>T</sup> grown on R2YE agar plates. (B) Induction of ferroverdin production by iron. (Top panels) Phenotypes. (Bottom left panel) HPLC profiles of the crude metabolite extracts. The HPLC profile analyses were performed with crude acetonitrile extracts of <named-content content-type="genus-species">S. lunaelactis</named-content> MM109<sup>T</sup> grown on R2YE agar plates (black line) or on R2YE medium supplied with 1&#x02009;mM FeCl<sub>3</sub> (green line). (Bottom right panel) Semiquantitative analysis of ferroverdin production (Ferroverdin A prod.) by <named-content content-type="genus-species">S. lunaelactis</named-content> MM109<sup>T</sup> grown on R2YE agar plates supplied with various concentrations of FeCl<sub>3</sub>. The areas of the integrated HPLC peaks of ferroverdin A (observed at 440&#x02009;nm) were normalized, and the value measured in R2YE plus 0.5&#x02009;mM FeCl<sub>3</sub> was fixed at 100%. Bars represent means of results from biological triplicates. AU, arbitrary units. (C) Extracted ion chromatograms (EIC) of the three ferroverdins detected in the full extract of <named-content content-type="genus-species">S. lunaelactis</named-content> MM109<sup>T</sup>. RA, relative abundance.</p></caption><graphic xlink:href="mBio.01230-19-f0002"/></fig><p>Under culture conditions allowing the production of ferroverdins, the crude extract of <named-content content-type="genus-species">S. lunaelactis</named-content> MM109<sup>T</sup> displayed antibacterial activity against Gram-positive bacteria, as exemplified by the observed growth inhibition against the test strain <named-content content-type="genus-species">Staphylococcus aureus</named-content> (<xref ref-type="fig" rid="fig3">Fig.&#x000a0;3A</xref>). As pure ferroverdins do not possess antibacterial activities against <named-content content-type="genus-species">S. aureus</named-content> (<xref ref-type="fig" rid="fig2">Fig.&#x000a0;2C</xref>, left panel), we undertook the extraction, purification, and identification of the antibacterial metabolites produced by <named-content content-type="genus-species">S. lunaelactis</named-content>. High-pressure liquid chromatography (HPLC) fractionation and subsequent analysis of the active fractions by UPLC-MS/MS identified molecular ion species corresponding to bagremycin A (<italic>m/z</italic> 254.0824 [M-H]<sup>-</sup>), bagremycin B (<italic>m/z</italic> 296.0931 [M-H]<sup>-</sup>), bagremycin C (<italic>m/z</italic> 415.0974 [M-H]<sup>-</sup>), bagremycin E (<italic>m/z</italic> 239.0714 [M-H]<sup>-</sup>), bagremycin F (<italic>m/z</italic> 429.1133 [M-H]<sup>-</sup>), and bagremycin G (<italic>m/z</italic> 282.0777 [M-H]<sup>-</sup>) (<xref ref-type="fig" rid="fig3">Fig.&#x000a0;3B</xref> and <xref ref-type="fig" rid="fig3">C</xref>; see also structures 4 to 9 in <xref ref-type="fig" rid="fig1">Fig.&#x000a0;1</xref>). Bagremycins are amino-aromatic antibiotics resulting from the condensation of 3-amino-4-hydroxybenzoic acid (3,4-AHBA) with <italic>p</italic>-vinylphenol (<xref rid="B22" ref-type="bibr">22</xref><xref ref-type="bibr" rid="B23">&#x02013;</xref><xref rid="B24" ref-type="bibr">24</xref>).</p><fig id="fig3" orientation="portrait" position="float"><label>FIG&#x000a0;3</label><caption><p>Production of bagremycins by <named-content content-type="genus-species">S. lunaelactis</named-content> MM109<sup>T</sup>. (A) Phenotype of <named-content content-type="genus-species">S. lunaelactis</named-content> MM109<sup>T</sup> grown on agar plates with R2YE plus 1&#x02009;mM FeCl<sub>3</sub> and paper disc diffusion assay assessing the antibacterial activity of the full acetonitrile extract (including both intracellular and extracellular extracts). (B) HPLC-separated fractions of the crude metabolite extract of <named-content content-type="genus-species">S. lunaelactis</named-content> MM109<sup>T</sup> (RA, relative abundance). Note the paper disc diffusion assay details revealing the antibacterial activity associated with pure bagremycin A (peak 4), and bagremycin B (peak 5); ctrl<sup>-</sup>, paper disc infused with acetonitrile used as negative control (no antibacterial activity). (C) Extracted ion chromatograms (EIC) of the six known bagremycins detected in the full extract of <named-content content-type="genus-species">S. lunaelactis</named-content> MM109<sup>T</sup>.</p></caption><graphic xlink:href="mBio.01230-19-f0003"/></fig><p>MM109<sup>T</sup> is the type strain of <named-content content-type="genus-species">S. lunaelactis</named-content>, but many other strains belonging to the species <named-content content-type="genus-species">S. lunaelactis</named-content> were isolated from different moonmilk deposits. Multilocus sequence analysis (MLSA) performed on 15 independently isolated <named-content content-type="genus-species">S. lunaelactis</named-content> strains grouped them into different clusters (<xref ref-type="fig" rid="fig4">Fig.&#x000a0;4A</xref>), and one representative of each cluster was investigated for the production of bagremycins and ferroverdins. The crude extracts of the selected eight different representative strains (MM25, MM31, MM37, MM40, MM83, MM91, MM109, and MM113) were analyzed by HPLC, which revealed that all strains except strain MM91 were able to produce at least one bagremycin and one ferroverdin (<xref ref-type="fig" rid="fig4">Fig.&#x000a0;4B</xref>). These data suggest that the production of bagremycins, like the production of ferroverdins, is a common feature of moonmilk-dwelling strains belonging to the species <named-content content-type="genus-species">S. lunaelactis</named-content>.</p><fig id="fig4" orientation="portrait" position="float"><label>FIG&#x000a0;4</label><caption><p>Production of ferroverdins and bagremycins by different <named-content content-type="genus-species">S. lunaelactis</named-content> strains. (A) Multilocus sequence analysis (MLSA) of moonmilk isolates belonging to the species <named-content content-type="genus-species">S. lunaelactis</named-content>. (B) HPLC profiles at the indicated retention times were determined for monitoring bagremycin and ferroverdin production by eight different <named-content content-type="genus-species">S. lunaelactis</named-content> strains grown on ISP7 medium.</p></caption><graphic xlink:href="mBio.01230-19-f0004"/></fig></sec><sec id="s2.2"><title>Identification of a BGC similar to <italic>fev</italic> and <italic>bag</italic> clusters in <named-content content-type="genus-species">S. lunaelactis</named-content> MM109<sup>T</sup>.</title><p>In order to identify the genes involved in the production of bagremycins (<italic>bag</italic>) and/or ferroverdins (<italic>fev</italic>) in <named-content content-type="genus-species">S. lunaelactis</named-content> MM109<sup>T</sup>, the genome of this strain (<xref rid="B28" ref-type="bibr">28</xref>) was mined using antiSMASH v4.0 software (<xref rid="B29" ref-type="bibr">29</xref>). A total of 37 BGCs were identified, specifically, 36 BGCs on the linear chromosome and 1 additional BGC on linear plasmid pSLUN1 (see <xref ref-type="supplementary-material" rid="figS1">Fig.&#x000a0;S1</xref> in the supplemental material). BGC 12 (from <named-content content-type="genus-species">S. lunaelactis</named-content> 21350 [SLUN_21350] to SLUN_21430 [<xref rid="B28" ref-type="bibr">28</xref>]) exhibits strong gene synteny with the bagremycin BGC from <italic>Streptomyces</italic> sp. T&#x000fc; 4128 (<xref rid="B30" ref-type="bibr">30</xref>, <xref rid="B31" ref-type="bibr">31</xref>), with high similarity between the predicted gene products (coverage, 99%; average identity, 86.2%; average similarity, 91.9%) (<xref ref-type="fig" rid="fig5">Fig.&#x000a0;5A</xref>) (<xref rid="tab1" ref-type="table">Table&#x000a0;1</xref>). Surprisingly, BGC 12 displayed similarly strong gene synteny and high similarity between its gene products and those seen with the <italic>fev</italic> cluster (GenBank accession no. <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/AB689797" assigning-authority="genbank">AB689797</ext-link>) of the ferroverdin producer <italic>Streptomyces</italic> sp. WK-5344 (coverage, 99%; average identity, 85.8%; average similarity, 91.3%) (<xref ref-type="fig" rid="fig5">Fig.&#x000a0;5A</xref>) (<xref rid="tab1" ref-type="table">Table&#x000a0;1</xref>). The levels of identity between the proposed <italic>fev</italic> cluster of <italic>Streptomyces</italic> sp. WK-5344 and the <italic>bag</italic> cluster of <italic>Streptomyces</italic> sp. T&#x000fc; 4128 were even greater, with (on average) 96% amino acid (aa) identity and 97.4% similarity (<xref ref-type="fig" rid="fig5">Fig.&#x000a0;5A</xref>) (<xref rid="tab1" ref-type="table">Table&#x000a0;1</xref>). The exceptionally high levels of average amino acid identity suggest that biosynthesis of bagremycins and biosynthesis of ferroverdins might be mediated by the same BGC. This conjecture was further supported by the results of comparative analysis of the BGCs involved in the production of other amino/nitroso-aromatic metabolites, i.e., the <italic>nsp</italic> gene cluster for biosynthesis of 4-hydroxy-3-nitrosobenzamide in <named-content content-type="genus-species">Streptomyces murayamaensis</named-content> (<xref rid="B32" ref-type="bibr">32</xref>) and the <italic>gri</italic> gene cluster involved in grixazone production in <named-content content-type="genus-species">Streptomyces griseus</named-content> (<xref rid="B33" ref-type="bibr">33</xref>). The <italic>nsp</italic> and <italic>gri</italic> clusters share seven homologous genes with those identified in the <italic>bag</italic>/<italic>fev</italic> cluster (<xref ref-type="fig" rid="fig5">Fig.&#x000a0;5A</xref>) (<xref rid="tab1" ref-type="table">Table&#x000a0;1</xref>), specifically, those encoding (i) the <italic>Streptomyces</italic> antibiotic regulatory protein (SARP)-family transcriptional activators (BagI, FevR, NspR, and GriR), (ii) the LuxR-family transcription regulators (BagY, FevT, NspT, and GriT), (iii) the 3,4-AHBA synthases (BagC, FevH, NspH, and GriH), (iv) the DhnA-type aldolase (BagB, FevI, NspI, and GriI), (v) the o-aminophenol oxidases (BagH, FevF, NspF, and GriF), (vi) the copper chaperones (BagZ, FevE, NspE, and GriE), and (vii) the flavin adenine dinucleotide (FAD)-dependent oxygenases (BagK/G. FavA1/A2, NspA, and GriA). Phylogeny analyses revealed that Fev and Bag proteins always branched together in clusters separated from Nsp and Gri proteins (<xref ref-type="fig" rid="fig5">Fig.&#x000a0;5B</xref>).</p><fig id="fig5" orientation="portrait" position="float"><label>FIG&#x000a0;5</label><caption><p>Comparative analysis of known BGCs involved in the production of nitroso-aromatic and amino-aromatic metabolites in <italic>Streptomyces</italic> spp. (A) Genetic organization of the BGCs involved in ferroverdin (<italic>fev</italic>), bagremycin (<italic>bag</italic>), 4-hydroxy-3-nitrosobenzamide (<italic>nsp</italic>), and grixazone (<italic>gri</italic>) production in <italic>Streptomyces</italic> spp. See <xref rid="tab1" ref-type="table">Table&#x000a0;1</xref> for the known function and/or predicted function associated with the product of each gene. (B) Phylogeny analysis of proteins conserved among the ferroverdin (<italic>fev</italic>), bagremycin (<italic>bag</italic>), 4-hydroxy-3-nitrosobenzamide (<italic>nsp</italic>), and grixazone (<italic>gri</italic>) BGCs. The trees were rooted by including as outgroup the proteins most similar to <named-content content-type="genus-species">S. lunaelactis</named-content> MM109<sup>T</sup> proteins.</p></caption><graphic xlink:href="mBio.01230-19-f0005"/></fig><table-wrap id="tab1" orientation="portrait" position="float"><label>TABLE&#x000a0;1</label><caption><p>Elements of the ferroverdin/bagremycin BGC in <italic>S. lunaelactis</italic> and comparative analysis of similar clusters in other <italic>Streptomyces</italic> species<xref ref-type="table-fn" rid="ngtab1.1"><sup><italic>a</italic></sup>
</xref></p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/></colgroup><thead><tr><th rowspan="1" colspan="1">Gene ID <break/>(SLUN)</th><th rowspan="1" colspan="1">Name<xref ref-type="table-fn" rid="ngtab1.2"><sup><italic>b</italic></sup>
</xref></th><th rowspan="1" colspan="1">Predicted<break/>function</th><th rowspan="1" colspan="1"><italic>fev</italic> ID in<break/><italic>Streptomyces</italic> sp.<break/>WK-5344</th><th rowspan="1" colspan="1"><italic>bag</italic> ID in<break/><italic>Streptomyces</italic> sp.<break/>T&#x000fc;-4128; accession no.</th><th rowspan="1" colspan="1"><italic>gri</italic> in<break/><italic>S. griseus</italic>
<break/>subsp. <italic>griseus</italic></th><th rowspan="1" colspan="1"><italic>nsp</italic> in<break/><named-content content-type="genus-species">S. murayamaensis</named-content></th></tr></thead><tbody><tr><td rowspan="1" colspan="1">21345</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Aminotransferase</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">23415 (NS); <break/><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/WP_122618577" assigning-authority="ncbi:protein">WP_122618577</ext-link></td><td rowspan="1" colspan="1">NF</td><td rowspan="1" colspan="1">NF</td></tr><tr><td colspan="7" rowspan="1"/></tr><tr><td rowspan="1" colspan="1">21350</td><td rowspan="1" colspan="1">ORF1</td><td rowspan="1" colspan="1">Prephenate dehydrogenase</td><td rowspan="1" colspan="1">89&#x02013;93; <break/><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/BAM73624" assigning-authority="ncbi:protein">BAM73624</ext-link></td><td rowspan="1" colspan="1"><italic>Pseudo</italic>-23410</td><td rowspan="1" colspan="1">NF</td><td rowspan="1" colspan="1">NF</td></tr><tr><td colspan="7" rowspan="1"/></tr><tr><td rowspan="1" colspan="1">21355</td><td rowspan="1" colspan="1"><italic>fevL</italic></td><td rowspan="1" colspan="1">Decarboxylase</td><td rowspan="1" colspan="1">88&#x02013;93; <break/><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/BAM73625" assigning-authority="ncbi:protein">BAM73625</ext-link></td><td rowspan="1" colspan="1">88&#x02013;93 (<italic>bagN</italic>); 23405/<break/><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/WP_122618385" assigning-authority="ncbi:protein">WP_122618385</ext-link></td><td rowspan="1" colspan="1">NF</td><td rowspan="1" colspan="1">NF</td></tr><tr><td colspan="7" rowspan="1"/></tr><tr><td rowspan="1" colspan="1">21360</td><td rowspan="1" colspan="1"><italic>fevK</italic></td><td rowspan="1" colspan="1">Decarboxylase</td><td rowspan="1" colspan="1">82&#x02013;89; <break/><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/BAM73626" assigning-authority="ncbi:protein">BAM73626</ext-link></td><td rowspan="1" colspan="1">82&#x02013;89 (<italic>bagM</italic>); 23400/<break/><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/WP_122618384" assigning-authority="ncbi:protein">WP_122618384</ext-link></td><td rowspan="1" colspan="1">NF</td><td rowspan="1" colspan="1">NF</td></tr><tr><td colspan="7" rowspan="1"/></tr><tr><td rowspan="1" colspan="1">21365</td><td rowspan="1" colspan="1"><italic>fevM</italic></td><td rowspan="1" colspan="1">Transcriptional regulator,<break/> MarR family</td><td rowspan="1" colspan="1">90&#x02013;92; <break/><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/BAM73627" assigning-authority="ncbi:protein">BAM73627</ext-link></td><td rowspan="1" colspan="1">90&#x02013;92 (<italic>bagL</italic>); 23395/<break/><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/WP_122618383" assigning-authority="ncbi:protein">WP_122618383</ext-link></td><td rowspan="1" colspan="1">NF</td><td rowspan="1" colspan="1">NF</td></tr><tr><td colspan="7" rowspan="1"/></tr><tr><td rowspan="1" colspan="1">21370</td><td rowspan="1" colspan="1"><italic>fevA1</italic></td><td rowspan="1" colspan="1">FAD-dependent <break/>oxygenase</td><td rowspan="1" colspan="1">79&#x02013;86; <break/><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/BAM73628" assigning-authority="ncbi:protein">BAM73628</ext-link></td><td rowspan="1" colspan="1">78&#x02013;86 (<italic>bagK</italic>); 23390/<break/><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/WP_122618382" assigning-authority="ncbi:protein">WP_122618382</ext-link></td><td rowspan="1" colspan="1">57&#x02013;69 (<italic>griA</italic>); <break/><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/BAF36643" assigning-authority="ncbi:protein">BAF36643</ext-link></td><td rowspan="1" colspan="1">51&#x02013;65 (<italic>nspA</italic>); <break/><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/BAJ08166" assigning-authority="ncbi:protein">BAJ08166</ext-link></td></tr><tr><td colspan="7" rowspan="1"/></tr><tr><td rowspan="1" colspan="1">21375</td><td rowspan="1" colspan="1"><italic>fevB</italic></td><td rowspan="1" colspan="1">Putative bagremycin <break/>transporter</td><td rowspan="1" colspan="1">88&#x02013;93; <break/><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/BAM73629" assigning-authority="ncbi:protein">BAM73629</ext-link></td><td rowspan="1" colspan="1">88&#x02013;93 (<italic>bagJ</italic>); 23385/<break/><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/WP_122618381" assigning-authority="ncbi:protein">WP_122618381</ext-link></td><td rowspan="1" colspan="1">57&#x02013;71 (<italic>griB</italic>); <break/><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/BAF36644" assigning-authority="ncbi:protein">BAF36644</ext-link></td><td rowspan="1" colspan="1">NS (<italic>orf2</italic>); <break/><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/BAJ08168" assigning-authority="ncbi:protein">BAJ08168</ext-link></td></tr><tr><td colspan="7" rowspan="1"/></tr><tr><td rowspan="1" colspan="1">21380</td><td rowspan="1" colspan="1"><italic>fevR</italic></td><td rowspan="1" colspan="1">SARP-family <break/>transcriptional <break/>activator</td><td rowspan="1" colspan="1">81&#x02013;87; <break/><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/BAM73630" assigning-authority="ncbi:protein">BAM73630</ext-link></td><td rowspan="1" colspan="1">80&#x02013;86 (<italic>bagI</italic>); 23380/<break/><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/AKA27633.1" assigning-authority="ncbi:protein">AKA27633.1</ext-link></td><td rowspan="1" colspan="1">47&#x02013;64 (<italic>griR</italic>); <break/><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/BAF36642" assigning-authority="ncbi:protein">BAF36642</ext-link></td><td rowspan="1" colspan="1">53&#x02013;68 (<italic>nspR</italic>); <break/><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/BAJ08169" assigning-authority="ncbi:protein">BAJ08169</ext-link></td></tr><tr><td colspan="7" rowspan="1"/></tr><tr><td rowspan="1" colspan="1">21385</td><td rowspan="1" colspan="1"><italic>fevF</italic></td><td rowspan="1" colspan="1"><italic>o</italic>-Aminophenol <break/>oxidase</td><td rowspan="1" colspan="1">89&#x02013;93; <break/><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/BAM73631" assigning-authority="ncbi:protein">BAM73631</ext-link></td><td rowspan="1" colspan="1">89&#x02013;93 (<italic>bagH</italic>); 23375/<break/><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/WP_122618379" assigning-authority="ncbi:protein">WP_122618379</ext-link></td><td rowspan="1" colspan="1">68&#x02013;78 (<italic>griF</italic>); <break/><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/BAF36648" assigning-authority="ncbi:protein">BAF36648</ext-link></td><td rowspan="1" colspan="1">60&#x02013;74 (<italic>nspF</italic>); <break/><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/BAJ08174" assigning-authority="ncbi:protein">BAJ08174</ext-link></td></tr><tr><td colspan="7" rowspan="1"/></tr><tr><td rowspan="1" colspan="1">21390</td><td rowspan="1" colspan="1"><italic>fevE</italic></td><td rowspan="1" colspan="1">Copper chaperon</td><td rowspan="1" colspan="1">73&#x02013;79; <break/><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/BAM73632" assigning-authority="ncbi:protein">BAM73632</ext-link></td><td rowspan="1" colspan="1"><italic>Pseudo</italic>-23370 (<italic>bagZ</italic>)</td><td rowspan="1" colspan="1">61&#x02013;74 (<italic>griE</italic>); <break/><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/BAF36647" assigning-authority="ncbi:protein">BAF36647</ext-link></td><td rowspan="1" colspan="1">57&#x02013;68 (<italic>nspE</italic>); <break/><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/BAJ08173" assigning-authority="ncbi:protein">BAJ08173</ext-link></td></tr><tr><td colspan="7" rowspan="1"/></tr><tr><td rowspan="1" colspan="1">21395</td><td rowspan="1" colspan="1"><italic>fevA2</italic></td><td rowspan="1" colspan="1">FAD-dependent <break/>oxygenase</td><td rowspan="1" colspan="1">83&#x02013;90; <break/><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/BAM73633" assigning-authority="ncbi:protein">BAM73633</ext-link></td><td rowspan="1" colspan="1">83&#x02013;90 (<italic>bagG</italic>); 23365/<break/><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/WP_122618378" assigning-authority="ncbi:protein">WP_122618378</ext-link></td><td rowspan="1" colspan="1">56&#x02013;69 (<italic>griA</italic>); <break/><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/BAF36643" assigning-authority="ncbi:protein">BAF36643</ext-link></td><td rowspan="1" colspan="1">52&#x02013;65 (<italic>nspA</italic>); <break/><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/BAJ08166" assigning-authority="ncbi:protein">BAJ08166</ext-link></td></tr><tr><td colspan="7" rowspan="1"/></tr><tr><td rowspan="1" colspan="1">21400</td><td rowspan="1" colspan="1"><italic>fevY</italic></td><td rowspan="1" colspan="1">Phospho-2-dehydro-3-<break/>deoxyheptonate <break/>aldolase</td><td rowspan="1" colspan="1">88&#x02013;94; <break/><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/BAM73634" assigning-authority="ncbi:protein">BAM73634</ext-link></td><td rowspan="1" colspan="1">88&#x02013;94 (<italic>bagF</italic>); 23360/<break/><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/WP_122618377" assigning-authority="ncbi:protein">WP_122618377</ext-link></td><td rowspan="1" colspan="1">NF</td><td rowspan="1" colspan="1">NF</td></tr><tr><td colspan="7" rowspan="1"/></tr><tr><td rowspan="1" colspan="1">21405</td><td rowspan="1" colspan="1"><italic>fevW</italic></td><td rowspan="1" colspan="1">Bagremycin synthetase</td><td rowspan="1" colspan="1">84&#x02013;89; <break/><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/BAM73635" assigning-authority="ncbi:protein">BAM73635</ext-link></td><td rowspan="1" colspan="1">84&#x02013;89 (<italic>bagE</italic>); 23355/<break/><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/WP_122618576" assigning-authority="ncbi:protein">WP_122618576</ext-link></td><td rowspan="1" colspan="1">NF</td><td rowspan="1" colspan="1">NF</td></tr><tr><td colspan="7" rowspan="1"/></tr><tr><td rowspan="1" colspan="1">21410</td><td rowspan="1" colspan="1"><italic>fevV</italic></td><td rowspan="1" colspan="1">Tyrosine ammonia-lyase</td><td rowspan="1" colspan="1">92&#x02013;95; <break/><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/BAM73636" assigning-authority="ncbi:protein">BAM73636</ext-link></td><td rowspan="1" colspan="1">91&#x02013;95 (<italic>bagA</italic>); 23350/<break/><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/WP_122618575" assigning-authority="ncbi:protein">WP_122618575</ext-link></td><td rowspan="1" colspan="1">NF</td><td rowspan="1" colspan="1">NF</td></tr><tr><td colspan="7" rowspan="1"/></tr><tr><td rowspan="1" colspan="1">21415</td><td rowspan="1" colspan="1"><italic>fevI</italic></td><td rowspan="1" colspan="1">DhnA-type aldolase</td><td rowspan="1" colspan="1">91&#x02013;96; <break/><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/BAM73637" assigning-authority="ncbi:protein">BAM73637</ext-link></td><td rowspan="1" colspan="1">91&#x02013;96 (<italic>bagB</italic>); 23345/<break/><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/WP_122618376" assigning-authority="ncbi:protein">WP_122618376</ext-link></td><td rowspan="1" colspan="1">72&#x02013;85 (<italic>griI</italic>); <break/><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/BAF36651" assigning-authority="ncbi:protein">BAF36651</ext-link></td><td rowspan="1" colspan="1">74&#x02013;85 (<italic>nspI</italic>); <break/><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/BAJ08171" assigning-authority="ncbi:protein">BAJ08171</ext-link></td></tr><tr><td colspan="7" rowspan="1"/></tr><tr><td rowspan="1" colspan="1">21420</td><td rowspan="1" colspan="1"><italic>fevH</italic></td><td rowspan="1" colspan="1">3,4-AHBA synthase</td><td rowspan="1" colspan="1">92&#x02013;96; <break/><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/BAM73638" assigning-authority="ncbi:protein">BAM73638</ext-link></td><td rowspan="1" colspan="1">92&#x02013;96 (<italic>bagC</italic>); 23340/<break/><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/WP_122618375" assigning-authority="ncbi:protein">WP_122618375</ext-link></td><td rowspan="1" colspan="1">77&#x02013;87 (<italic>griH</italic>); <break/><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/BAF36650" assigning-authority="ncbi:protein">BAF36650</ext-link></td><td rowspan="1" colspan="1">79&#x02013;89 (<italic>nspH</italic>); <break/><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/BAJ08172" assigning-authority="ncbi:protein">BAJ08172</ext-link></td></tr><tr><td colspan="7" rowspan="1"/></tr><tr><td rowspan="1" colspan="1">21425</td><td rowspan="1" colspan="1"><italic>fevO</italic></td><td rowspan="1" colspan="1">Hypothetical protein</td><td rowspan="1" colspan="1">86&#x02013;95; <break/><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/BAM73639" assigning-authority="ncbi:protein">BAM73639</ext-link></td><td rowspan="1" colspan="1">85&#x02013;94; 23335/<break/><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/WP_122618374" assigning-authority="ncbi:protein">WP_122618374</ext-link></td><td rowspan="1" colspan="1">NF</td><td rowspan="1" colspan="1">NF</td></tr><tr><td colspan="7" rowspan="1"/></tr><tr><td rowspan="1" colspan="1">21430</td><td rowspan="1" colspan="1"><italic>fevT</italic></td><td rowspan="1" colspan="1">LuxR-family transcriptional <break/>regulator</td><td rowspan="1" colspan="1">84&#x02013;92; <break/><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/BAM73640" assigning-authority="ncbi:protein">BAM73640</ext-link></td><td rowspan="1" colspan="1">84&#x02013;92 (<italic>bagY</italic>); 23330/<break/><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/WP_122618373" assigning-authority="ncbi:protein">WP_122618373</ext-link></td><td rowspan="1" colspan="1">63&#x02013;78 (<italic>griT</italic>); <break/><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/BAF36640" assigning-authority="ncbi:protein">BAF36640</ext-link></td><td rowspan="1" colspan="1">62&#x02013;76 (<italic>nspT</italic>); <break/><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/BAJ08165" assigning-authority="ncbi:protein">BAJ08165</ext-link></td></tr><tr><td colspan="7" rowspan="1"/></tr><tr><td rowspan="1" colspan="1">21435</td><td rowspan="1" colspan="1">ORF2</td><td rowspan="1" colspan="1">Carboxymuconolactone <break/>decarboxylase</td><td rowspan="1" colspan="1">NS; <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/BAM73641" assigning-authority="ncbi:protein">BAM73641</ext-link></td><td rowspan="1" colspan="1"><italic>Pseudo</italic>-23325</td><td rowspan="1" colspan="1">NF</td><td rowspan="1" colspan="1">NF</td></tr></tbody></table><table-wrap-foot><fn fn-type="other" id="ngtab1.1"><label>a</label><p><italic>bag</italic>, bagremycin cluster (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/NZ_QTSY01000069" assigning-authority="genbank">NZ_QTSY01000069</ext-link>) (DXM28_RS); <italic>fev</italic>, ferroverdin cluster (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/AB689797" assigning-authority="genbank">AB689797</ext-link>); <italic>gri</italic>, grixazone cluster (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/AB259663" assigning-authority="genbank">AB259663</ext-link>); <italic>nsp</italic>, nitrosobenzamide cluster (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/AB530136" assigning-authority="genbank">AB530136</ext-link>). Abbreviations: ID, identifier; sim, similarity; NA, sequence not available; NS, not similar; NF, none found.</p></fn><fn fn-type="other" id="ngtab1.2"><label>b</label><p>Gene names were provided based on the <italic>fev</italic> cluster of <italic>Streptomyces</italic> WK-5344 (GenBank accession no. <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/AB689797.1" assigning-authority="genbank">AB689797.1</ext-link>). Paired numbers refer to the percentage of amino acid identity and similarity, respectively.</p></fn></table-wrap-foot></table-wrap><supplementary-material content-type="local-data" id="figS1"><object-id pub-id-type="doi">10.1128/mBio.01230-19.1</object-id><label>FIG&#x000a0;S1</label><p>Schematic representation of <named-content content-type="genus-species">S. lunaelactis</named-content> MM109<sup>T</sup> chromosome and its two extrachromosomal plasmids. (A) Chromosome. From the outside to the inside, the concentric tracks represent the following: nucleotide position; predicted BGCs with associated labels; coding DNA sequences (CDSs) on the forward strand; CDSs on the reverse strand; tRNA (orange) and rRNA (magenta) genes; per-base read coverage (green and red for above and below average, respectively; window size&#x02009;=&#x02009;10,000; base step size&#x02009;=&#x02009;1,000); GC content (GC%; window size&#x02009;=&#x02009;10,000; base step size&#x02009;=&#x02009;1,000); GC skew ([G&#x02009;+&#x02009;C]/[G &#x02212; C], window size&#x02009;=&#x02009;8,396; base step size&#x02009;=&#x02009;839); cumulative GC skew. The position of the predicted origin of replication (OriC) is indicated. (B) Linear plasmid pSLUN1. (C) Circular plasmid pSLUN2. The same track coloring applies for the plasmids. (The coverage and GC content sliding averages have a window size&#x02009;of 1,000 bp and a base step size&#x02009;of 100 bp). Download <inline-supplementary-material id="fS1" mimetype="image" mime-subtype="tif" xlink:href="mBio.01230-19-sf001.tif" content-type="local-data">FIG&#x000a0;S1, TIF file, 1.6 MB</inline-supplementary-material>.</p><permissions><copyright-statement>Copyright &#x000a9; 2019 Martinet et al.</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>Martinet et al.</copyright-holder><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/"><license-p>This content is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>.</license-p></license></permissions></supplementary-material><p>Finally, only one single BGC is similar to the <italic>fev</italic> and <italic>bag</italic> gene clusters in <named-content content-type="genus-species">S. lunaelactis</named-content> MM109<sup>T</sup> as well as in the genomes of 16 other <named-content content-type="genus-species">S. lunaelactis</named-content> strains. This makes it extremely unlikely that bagremycins and ferroverdins should be specified by two different BGCs. A plausible pathway for the synthesis of both bagremycins and ferroverdin A from the <italic>fev</italic>/<italic>bag</italic> cluster is proposed in the Discussion (see also <xref ref-type="fig" rid="fig8">Fig.&#x000a0;8</xref>).</p></sec><sec id="s2.3"><title>Inactivation and/or duplication of <italic>fevR</italic> affects both ferroverdin and bagremycin production.</title><p>Among the <named-content content-type="genus-species">S. lunaelactis</named-content> strains that were collected from the moonmilk samples, strain <named-content content-type="genus-species">S. lunaelactis</named-content> MM91, which does possess a complete <italic>fev</italic>/<italic>bag</italic> cluster (GenBank accession no. <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/MG708299" assigning-authority="genbank">MG708299</ext-link>), failed to produce the ferroverdin-associated green pigmentation under conditions of growth in iron-containing media (<xref ref-type="fig" rid="fig6">Fig.&#x000a0;6A</xref> and <xref ref-type="fig" rid="fig6">B</xref>).</p><fig id="fig6" orientation="portrait" position="float"><label>FIG&#x000a0;6</label><caption><p>FevR (BagI) is involved in the production of both ferroverdin A and bagremycins. (A) Phenotypes of <named-content content-type="genus-species">S. lunaelactis</named-content> strains MM109<sup>T</sup> and MM91 grown in media activating (R2YE plus FeCl<sub>3</sub>) or not inducing (R2YE) the production of ferroverdin A. (B) Semiquantitative analysis (HPLC) of ferroverdin A produced by these strains. (C) Semiquantitative analysis (HPLC) of bagremycins produced by <named-content content-type="genus-species">S. lunaelactis</named-content> strains MM109<sup>T</sup> and MM91. (D) Identification in the <italic>fev</italic> cluster of <named-content content-type="genus-species">S. lunaelactis</named-content> strain MM91 (accession number <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/MG708299" assigning-authority="genbank">MG708299</ext-link>) of the in-frame deletion at nt position +337&#x02009;of <italic>fevR</italic> encoding the SARP-family transcription activator. (E) Details of HPLC profiles focused on peaks associated with bagremycin A, bagremycin B, bagremycin F, and ferroverdins from extracts of mutant strains of <named-content content-type="genus-species">S. lunaelactis</named-content> MM109<sup>T</sup> in which <italic>fevR</italic> is inactivated (&#x003a9;<italic>fevR</italic>) or with one supplementary copy of <italic>fevR</italic> (<italic>fevR</italic><sup>+</sup>). Abs, absorbance. WT, wild type.</p></caption><graphic xlink:href="mBio.01230-19-f0006"/></fig><p>MM91 also showed reduced production of all bagremycins except bagremycin B (<xref ref-type="fig" rid="fig6">Fig.&#x000a0;6C</xref>). The phenotype of <named-content content-type="genus-species">S. lunaelactis</named-content> MM91 allowed a forward genetic approach to assess if the <italic>fev</italic> cluster is indeed responsible for production of both bagremycins and ferroverdins. Genome sequencing and single nucleotide polymorphism (SNP) analysis of <named-content content-type="genus-species">S. lunaelactis</named-content> strain MM91 revealed a deletion at nucleotide (nt) position +337 of SLUN_21380 (<italic>bagI</italic> or <italic>fevR</italic>), which encodes the likely pathway-specific activator of the BGC (<xref ref-type="fig" rid="fig6">Fig.&#x000a0;6D</xref>). This deletion resulted in a frameshift leading to a premature stop codon, 17 amino acids downstream of the deletion, and thus in a truncated (and likely inactive) protein.</p><p>To ascertain whether FevR/BagI is required for both ferroverdin and bagremycin production, the SLUN_21380 gene was first interrupted in strain <named-content content-type="genus-species">S. lunaelactis</named-content> MM109<sup>T</sup> by insertion of a thiostreptone resistance cassette. Introduction of plasmid pBDF028 into spores of MM109<sup>T</sup> allowed isolation of thiostreptone-resistant clones in which occurred a single recombination event corresponding to a 791-bp internal fragment of SLUN_21380 (<italic>fevR</italic>/<italic>bagI</italic>). The single-crossover event resulted in a duplication of <italic>fevR</italic>, with the first copy lacking the last 86&#x02009;nt, resulting in a truncated FevR protein, and the second copy lacking the promoter region and the first 116&#x02009;nt. One clone (referred to as strain &#x003a9;<italic>fevR</italic> here, where &#x0201c;&#x003a9;&#x0201d; represents inactivation by interruption) was selected for further analyses. Strain &#x003a9;<italic>fevR</italic> displayed loss of the ferroverdin-associated green pigmentation under conditions of growth on iron-supplemented R2YE medium. HPLC analysis of the crude extracts of strain &#x003a9;<italic>fevR</italic> confirmed the absence of ferroverdins and bagremycins (<xref ref-type="fig" rid="fig6">Fig.&#x000a0;6E</xref>). These data suggest that FevR/BagI is indeed the pathway-specific activator for the BGC, and this interpretation was further supported by the observation that introduction of an additional copy of <italic>fevR</italic>/<italic>bagI</italic> into <named-content content-type="genus-species">S. lunaelactis</named-content> MM109<sup>T</sup> resulted in increased production of both ferroverdins and bagremycins (<xref ref-type="fig" rid="fig6">Fig.&#x000a0;6E</xref>). Finally, complementation of &#x003a9;<italic>fevR</italic> (strain MM109BD3; <xref rid="tab2" ref-type="table">Table&#x000a0;2</xref>) by the low-copy-number plasmid harboring an intact copy of <italic>fevR</italic> with its own promoter allowed restoration of production of both ferroverdin and bagremycin (not shown).</p><table-wrap id="tab2" orientation="portrait" position="float"><label>TABLE&#x000a0;2</label><caption><p>Plasmids and strains used in this study<xref ref-type="table-fn" rid="ngtab2.1"><sup><italic>a</italic></sup>
</xref></p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col span="1"/><col span="1"/><col span="1"/></colgroup><thead><tr><th rowspan="1" colspan="1">Plasmids <break/>and strains</th><th rowspan="1" colspan="1">Description</th><th rowspan="1" colspan="1">Source or<break/>reference(s)</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Plasmids</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;pJET1.2/blunt</td><td rowspan="1" colspan="1"><named-content content-type="genus-species">E. coli</named-content> plasmid used for high-efficiency blunt-end cloning of PCR products (Amp<sup>r</sup>)</td><td rowspan="1" colspan="1">Thermo Scientific</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;pBDF019</td><td rowspan="1" colspan="1">pJET1.2 derivative containing the <italic>slun21380</italic> gene (<italic>fevR</italic>) and its upstream (217-bp) and <break/>downstream (360-bp) regions (Amp<sup>r</sup>)</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;pSET152</td><td rowspan="1" colspan="1">Integrative vector transmissible by conjugation from <named-content content-type="genus-species">E. coli</named-content> to <italic>Streptomyces</italic> spp. [<italic>lacZ&#x003b1;</italic>,<break/>
<italic>ori</italic> (pUC18), <italic>aac(3)IV</italic> (Apra<sup>r</sup>), <italic>oriT</italic> (RK2), <italic>attP</italic> (&#x000d8;C31), <italic>int</italic> (&#x000d8;C31)]</td><td rowspan="1" colspan="1"><xref rid="B42" ref-type="bibr">42</xref></td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;pBDF021</td><td rowspan="1" colspan="1">pSET152 derivative containing the insertion of pBDF019 cloned in EcoRI and XbaI sites (Apra<sup>r</sup>)</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;pBDF027</td><td rowspan="1" colspan="1">pJET1.2 derivative containing an internal fragment (791 bp amplified with <italic>fevR</italic>+118f_<italic>Xba</italic>I <break/>and <italic>fevR</italic>+909r_<italic>Pst</italic>I primers) of the <italic>slun21380</italic> (<italic>fevR</italic>) coding sequence (Amp<sup>r</sup>)</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;pSET151</td><td rowspan="1" colspan="1">Nonreplicating plasmid in <italic>Streptomyces</italic> spp. [<italic>lacZ&#x003b1;</italic>, <italic>oriT</italic> (RK2), <italic>xylE</italic>, <italic>tsr</italic> (Thio<sup>r</sup>), <italic>bla</italic> (Amp<sup>r</sup>),<break/>
<italic>ori</italic> (pUC19)]</td><td rowspan="1" colspan="1"><xref rid="B42" ref-type="bibr">42</xref>, <xref rid="B43" ref-type="bibr">43</xref></td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;pBDF028</td><td rowspan="1" colspan="1">pSET151 derivative containing the insertion of pBDF027 cloned in XbaI and PstI sites <break/>(Amp<sup>r</sup>, Thio<sup>r</sup>)</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;pUZ8002</td><td rowspan="1" colspan="1">Nontransmissible plasmid supplying transfer functions for mobilization of <italic>ori</italic>T-containing <break/>vectors from <named-content content-type="genus-species">E. coli</named-content> to <italic>Streptomyces</italic> spp. (Kan<sup>r</sup>)</td><td rowspan="1" colspan="1"><xref rid="B41" ref-type="bibr">41</xref></td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;pAU3-45</td><td rowspan="1" colspan="1">pSET152 derivative with a thiostrepton resistance gene inserted into the blunted NheI <break/>restriction site [<italic>lacZ&#x003b1;</italic>, <italic>ori</italic> (pUC18), <italic>aac(3)IV</italic> (Apra<sup>r</sup>), <italic>oriT</italic> (RK2), <italic>attP</italic> (&#x000d8;C31), <italic>int</italic> (&#x000d8;C31),<break/>
<italic>tsr</italic> (Thio<sup>r</sup>)]</td><td rowspan="1" colspan="1"><xref rid="B44" ref-type="bibr">44</xref></td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;pBDF029</td><td rowspan="1" colspan="1">pBDF022 derivative containing the apramycin resistance cassette from pIJ773 cloned in <break/>PstI and HindIII sites (Thio<sup>r</sup>, Amp<sup>r</sup>, Apra<sup>r</sup>)</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;pIJ773</td><td rowspan="1" colspan="1">pBluescript II SK(+)-based plasmid containing the apramycin resistance cassette [<italic>oriT</italic> (RK2)<break/> + <italic>aac(3)IV</italic> (Apra<sup>r</sup>)] flanked by FRT (FLP recognition target) recombination sites</td><td rowspan="1" colspan="1"><xref rid="B43" ref-type="bibr">43</xref></td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;pBDF022</td><td rowspan="1" colspan="1">pHJL401 derivative containing the insert of pBDF019 cloned in EcoRI and XbaI sites <break/>(Thio<sup>r</sup>, Amp<sup>r</sup>)</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;pHJL401</td><td rowspan="1" colspan="1">Intermediate-copy-number (&#x0223c;10 copies) vector in <italic>Streptomyces</italic> spp. [<italic>lacZ&#x003b1;</italic>, <italic>ori</italic> (pUC19),<break/>
<italic>ori</italic> (SCP2), <italic>tsr</italic> (Thio<sup>r</sup>), <italic>bla</italic> (Amp<sup>r</sup>)]</td><td rowspan="1" colspan="1"><xref rid="B42" ref-type="bibr">42</xref></td></tr><tr><td colspan="3" rowspan="1"/></tr><tr><td rowspan="1" colspan="1">Strains</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;<named-content content-type="genus-species">E. coli</named-content> DH5&#x003b1;</td><td rowspan="1" colspan="1">General cloning host</td><td rowspan="1" colspan="1">Gibco-BRL</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;<named-content content-type="genus-species">E. coli</named-content> ET12567</td><td rowspan="1" colspan="1">Nonmethylating (<italic>dam</italic>, <italic>dcm</italic>, <italic>hsdS</italic> null mutants) host for transfer of plasmid DNA into <break/><italic>Streptomyces</italic> spp., used together with pUZ8002 (Cml<sup>r</sup>, Tet<sup>r</sup>)</td><td rowspan="1" colspan="1"><xref rid="B45" ref-type="bibr">45</xref></td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;<named-content content-type="genus-species">Streptomyces lunaelactis</named-content><break/> MM109<sup>T</sup></td><td rowspan="1" colspan="1">Wild-type and reference strain of <named-content content-type="genus-species">Streptomyces lunaelactis</named-content></td><td rowspan="1" colspan="1"><xref rid="B25" ref-type="bibr">25</xref></td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;<named-content content-type="genus-species">Streptomyces lunaelactis</named-content><break/> MM91</td><td rowspan="1" colspan="1">Wild-type strain <named-content content-type="genus-species">Streptomyces lunaelactis</named-content> MM91</td><td rowspan="1" colspan="1"><xref rid="B26" ref-type="bibr">26</xref></td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;<named-content content-type="genus-species">Streptomyces lunaelactis</named-content><break/> MM109BD1 (&#x003a9;<italic>fevR</italic>)</td><td rowspan="1" colspan="1">MM109 derivative with pBDF028 inserted to disrupt gene <italic>slun21380</italic> (<italic>fevR</italic>) (Thio<sup>r</sup>)</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;<named-content content-type="genus-species">Streptomyces lunaelactis</named-content><break/> MM109BD2 (<italic>fevR</italic><sup>+</sup>)</td><td rowspan="1" colspan="1">MM109<sup>T</sup> derivative with pBDF021 inserted to add an additional copy of <italic>slun21380</italic><break/> (<italic>fevR</italic>) controlled by its native promoter (Apra<sup>r</sup>)</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;<named-content content-type="genus-species">Streptomyces lunaelactis</named-content><break/> MM109BD3</td><td rowspan="1" colspan="1">Complementation of strain MM109BD1 (&#x003a9;<italic>fevR</italic>) with pBDF029 (Thio<sup>r</sup>, Apra<sup>r</sup>)</td><td rowspan="1" colspan="1">This study</td></tr></tbody></table><table-wrap-foot><fn fn-type="other" id="ngtab2.1"><label>a</label><p>Amp<sup>r</sup>, ampicillin resistance; <italic>lacZ&#x003b1;</italic>, LacZ galactosidase alpha subunit coding sequence; <italic>ori</italic> (pUC18/pUC19), origin of replication of the pUC18/pUC19 plasmid (<named-content content-type="genus-species">E. coli</named-content>); <italic>aac(</italic>
3<italic>)IV</italic>, apramycin resistance marker; Apra<sup>r</sup>, apramycin resistance; <italic>oriT</italic> (RK2), origin of conjugative transfer from plasmid RK2; <italic>attP</italic> (&#x000d8;C31), phage attachment site of the &#x000d8;C31 integrase [= <italic>int</italic> (&#x000d8;C31)]; <italic>xylE</italic>, catechol 2,3-dioxygenase (reporter gene); <italic>tsr</italic>, thiostrepton resistance gene; Thio<sup>r</sup>, thiostrepton resistance; <italic>bla</italic>, ampicillin resistance gene; <italic>dam</italic>, <italic>dcm</italic>, <italic>hsdS</italic>, genotype of methylase-deficient <named-content content-type="genus-species">E. coli</named-content> strain; Cml<sup>r</sup>, chloramphenicol resistance; Tet<sup>r</sup>, tetracycline resistance.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s2.4"><title>Iron is required for production of <italic>p</italic>-vinylphenyl-3,4-NHBA but its presence not mandatory for bagremycin biosynthesis.</title><p>If ferroverdins are detected only when iron is supplied in the cultivation media, a key issue that remains unaddressed is whether iron is required only for complexation of the <italic>p</italic>-vinylphenyl-3,4-NHBA monomers (and/or the other monomers required for ferroverdin B and C) or whether iron is necessary for the synthesis of <italic>p</italic>-vinylphenyl-3,4-NHBA, the monomer of ferroverdins. An HPLC chromatogram of extracts of <named-content content-type="genus-species">S. lunaelactis</named-content> MM109<sup>T</sup> grown on R2YE and R2YE supplied with 1&#x02009;mM FeCl<sub>3</sub> revealed the presence of the <italic>p</italic>-vinylphenyl-3,4-NHBA monomer only when strain MM109<sup>T</sup> was grown under conditions of high levels of iron (<xref ref-type="fig" rid="fig7">Fig.&#x000a0;7A</xref>). HPLC fractionation and subsequent UPLC-MS/MS analysis confirmed the presence of a molecular ion species that corresponded to <italic>p</italic>-vinylphenyl-3,4-NHBA (<italic>m/z</italic> 268.06 [M<sup>-</sup>]) (<xref ref-type="fig" rid="fig7">Fig.&#x000a0;7B</xref> and <xref ref-type="fig" rid="fig7">C</xref>). Instead, bagremycins were detected under both sets of conditions (<xref ref-type="supplementary-material" rid="figS2">Fig.&#x000a0;S2</xref>), suggesting that, in contrast to the results seen with <italic>p</italic>-vinylphenyl-3,4-NHBA, iron overload is not mandatory for their biosynthesis. Thus, iron is not only required for complexation of the three <italic>p</italic>-vinylphenyl-3,4-NHBA ligands with ferrous ion and for generation of ferroverdin A but is also necessary for their biosynthesis.</p><fig id="fig7" orientation="portrait" position="float"><label>FIG&#x000a0;7</label><caption><p>Iron supply is mandatory for production of <italic>p</italic>-vinylphenyl-3-nitroso-4-hydroxybenzoate. (A) (Left panel) HPLC chromatogram showing the identification of <italic>p</italic>-vinylphenyl-3-nitroso-4-hydroxybenzoate in the extracts of <named-content content-type="genus-species">S. lunaelactis</named-content> MM109 grown on R2YE plus 1&#x02009;mM FeCl<sub>3</sub> (green curve) and the (right panel) absorbance spectrum from 200 to 800&#x02009;nm of <italic>p</italic>-vinylphenyl-3-nitroso-4-hydroxybenzoate. Note the absence of the compound when <named-content content-type="genus-species">S. lunaelactis</named-content> MM109 is grown on R2YE (black line). (B) Mass spectrum of the compound present in the chromatographic peak and its proposed structure. (C) MS/MS spectra of <italic>p</italic>-vinylphenyl-3-nitroso-4-hydroxybenzoate with the proposed fragmentation mechanism.</p></caption><graphic xlink:href="mBio.01230-19-f0007"/></fig><supplementary-material content-type="local-data" id="figS2"><object-id pub-id-type="doi">10.1128/mBio.01230-19.2</object-id><label>FIG&#x000a0;S2</label><p>Identification of bagremycin A (left graph), bagremycin B (middle graph), and bagremycin G (right graph) in the culture extracts of <named-content content-type="genus-species">Streptomyces lunaelactis</named-content> MM109 grown on R2YE (black curve) and on R2YE plus 1 mM FeCl<sub>3</sub> (green curve). Download <inline-supplementary-material id="fS2" mimetype="image" mime-subtype="tif" xlink:href="mBio.01230-19-sf002.tif" content-type="local-data">FIG&#x000a0;S2, TIF file, 0.2 MB</inline-supplementary-material>.</p><permissions><copyright-statement>Copyright &#x000a9; 2019 Martinet et al.</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>Martinet et al.</copyright-holder><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/"><license-p>This content is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>.</license-p></license></permissions></supplementary-material></sec></sec><sec sec-type="discussion" id="s3"><title>DISCUSSION</title><p>In this work, we provide genomic, genetic, and metabolomic evidence that a single BGC (<italic>fev</italic>/<italic>bag</italic>) is responsible for the synthesis of both ferroverdins and bagremycins. That a single BGC is responsible for the production of several related compounds is not unusual, but several features make the case of the <italic>fev</italic>/<italic>bag</italic> BGC unique. For example, the chemical compositions of ferroverdins and bagremycins (nitroso-aromatic versus amino-aromatic compounds) are different, as are their structural organizations (trimers versus monomers), whereas these two characteristics are conserved in other BGCs producing multiple compounds. But what makes this biosynthetic pathway exceptional is that the bagremycins and <italic>p</italic>-vinylphenyl-3,4-NHBA, the monomer of ferroverdins, are not produced under the same culture conditions. Indeed, excess iron supply is mandatory for <italic>p</italic>-vinylphenyl-3,4-NHBA production and for its subsequent complexation to a tripartite molecule, while the bagremycins are produced under conditions of low iron levels. Thus, iron is a key molecule that determines the distinct biological activities produced by <named-content content-type="genus-species">S. lunaelactis</named-content>: bagremycins display antibacterial, antifungal, and antiproliferative activities, presumably in order to inhibit growth of neighboring competing bacteria and fungi and/or to control self-proliferation, while <italic>p</italic>-vinylphenyl-3,4-NHBA production would be required (to limit iron-mediated oxidative damage) only when iron excess constitutes a main threat. The change of the amino in a nitroso group in bagremycin allows complexation with iron, which strongly suggests an evolutionary driver for this chemical diversification.</p><p>We propose a possible biosynthetic pathway for both bagremycins and ferroverdins (<xref ref-type="fig" rid="fig8">Fig.&#x000a0;8</xref>) on the basis of the deduced function of the different components of the <italic>bag/fev</italic> clusters and of the current knowledge on the biosynthetic pathway of bagremycins (<xref rid="B22" ref-type="bibr">22</xref>, <xref rid="B30" ref-type="bibr">30</xref>, <xref rid="B31" ref-type="bibr">31</xref>, <xref rid="B34" ref-type="bibr">34</xref>). In addition, as biosynthesis is known to occur for two other types of amino/nitroso-aromatic compounds, namely, grixazones (<italic>gri</italic> genes) and 4-hydroxy-3-nitrosobenzamide (<italic>nsp</italic> genes), the available information regarding these BGCs is useful to predict steps shared by the studied pathways.</p><fig id="fig8" orientation="portrait" position="float"><label>FIG&#x000a0;8</label><caption><p>Proposed pathway for biosynthesis of bagremycin and ferroverdin.</p></caption><graphic xlink:href="mBio.01230-19-f0008"/></fig><p>As demonstrated previously, bagremycin A is derived from precursors <italic>p</italic>-vinylphenol and 3-amino-4-hydroxybenzoic acid (3,4-AHBA) (<xref rid="B22" ref-type="bibr">22</xref>). The <italic>p</italic>-vinylphenol precursor is generated in two steps from <sc>l</sc>-tyrosine, with the first step consisting of deamination by FevV/BagA in <italic>trans</italic>-coumaric acid and the second step being decarboxylation in <italic>p</italic>-vinylphenol by FevK (BagM) and FevL (BagN). Indeed, FevK and FevL form a UbiX-UbiD system in which UbiD is a decarboxylase that requires prenylated flavin mononucleotide (FMN) as a cofactor, which is provided by the flavin prenyltransferase UbiX (<xref rid="B35" ref-type="bibr">35</xref>). Regarding the second precursor, 3,4-AHBA, it was demonstrated previously that it is formed from dihydroxyacetone phosphate (DHAP) and <sc>l</sc>-aspartic-4-semialdehyde (ASA) through two reactions catalyzed by BagB (FevI) and BagC (FevH) (<xref rid="B30" ref-type="bibr">30</xref>). Condensation of <italic>p</italic>-vinylphenol and 3,4-AHBA to form bagremycin A would be mediated by FevW, which shows high levels of similarity to proteins of the phenylacetate-CoA ligase family, which catalyze the condensation of two molecules by their carboxylic acid and alcohol moieties through adenylation.</p><p>Regarding the synthesis of <italic>p</italic>-vinylphenyl-3,4-NHBA, the monomer of ferroverdin A and a major monomer of other ferroverdins, we propose that it would directly result from precursors <italic>p</italic>-vinylphenol and 4-hydroxy-3-nitrosobenzoic acid (4,3-HNBA) (<xref ref-type="fig" rid="fig7">Fig.&#x000a0;7</xref>). Direct generation of 4.3-HNBA would occur via the nitrosation of 3,4-AHBA and would be mediated by the copper-containing oxidase FevF (with FevE as chaperone). FevF is a copper-containing oxidase which is orthologous to NspF and GriF, while FevE is a copper chaperone orthologous to NspE and GriE (<xref rid="tab1" ref-type="table">Table&#x000a0;1</xref>). NspE bring two coppers to NspF, which converts 3-amino-4-hydroxybenzamide to 4-hydroxy-3-nitrosobenzamide in <named-content content-type="genus-species">S. murayamaensis</named-content> (<xref rid="B32" ref-type="bibr">32</xref>, <xref rid="B36" ref-type="bibr">36</xref>). Likewise, GriE donates two coppers to GriF, which converts <italic>o</italic>-aminophenol into <italic>o</italic>-quinone imine in <named-content content-type="genus-species">Streptomyces griseus</named-content> (<xref rid="B37" ref-type="bibr">37</xref>). Since these FevF/FevE orthologous proteins mediate the oxidation of 3.4-AHBA-like substrates to generate quinone imine moieties which would be consecutively nitrosylated, we suggest that both of these enzymes are able to mediate the transformation of 3,4-AHBA to 4,3-HNBA. Condensation of 4,3-HNBA with <italic>p</italic>-vinylphenol by FevW would result in the formation of <italic>p</italic>-vinylphenyl-3-nitroso-4-hydroxybenzoate, the monomer of ferroverdins.</p><p>Finally, in addition to the role of iron as a vital element for growth (<xref rid="B38" ref-type="bibr">38</xref>, <xref rid="B39" ref-type="bibr">39</xref>), morphogenesis, and metabolite production (<xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B39" ref-type="bibr">39</xref>, <xref rid="B40" ref-type="bibr">40</xref>), our work reveals an unprecedented complexity of natural product biosynthetic pathways where this element is also an environmental trigger able to change the pattern of natural compounds produced by a single BGC. By revealing an exception to the concept that a single BGC should produce a single type of bioactive molecules, our results also highlight the difficulty of estimating the metabolic potential of an organism on the basis of genomic information alone.</p></sec><sec sec-type="materials|methods" id="s4"><title>MATERIALS AND METHODS</title><sec id="s4.1"><title>Strains and culture conditions.</title><p>All strains used in this study are listed in <xref rid="tab1" ref-type="table">Table&#x000a0;1</xref>. <named-content content-type="genus-species">Escherichia coli</named-content> strains were grown in liquid LB or on solid LB medium agar plates and incubated at 37&#x000b0;C. Media used for solid <italic>Streptomyces</italic> cultures were R2YE, SFM, and ISP7 agar plates, which were incubated at 28&#x000b0;C. When required, the antibiotics thiostreptone, kanamycin, nalidixic acid, and ampicillin were added in the culture media. The type strain <named-content content-type="genus-species">S. lunaelactis</named-content> MM109<sup>T</sup> (<xref rid="B25" ref-type="bibr">25</xref>) and other <named-content content-type="genus-species">S. lunaelactis</named-content> strains were isolated from the cave &#x0201c;Grotte des Collemboles&#x02019; Collemboles&#x0201d; (Comblain-au-Pont, Belgium) (<xref rid="B25" ref-type="bibr">25</xref><xref ref-type="bibr" rid="B26">&#x02013;</xref><xref rid="B27" ref-type="bibr">27</xref>). The medium compositions used and the methods associated with <italic>Streptomyces</italic> species were all as described previously (<xref rid="B41" ref-type="bibr">41</xref>).</p></sec><sec id="s4.2"><title>Creation of <italic>fevR</italic> knockout and overexpression mutants in <named-content content-type="genus-species">S. lunaelactis</named-content> MM109.</title><p>In order to assess the effect of <italic>fevR</italic>/<italic>bagI</italic> on production of both bagremycin and ferroverdin, we first generated a <named-content content-type="genus-species">S. lunaelactis</named-content> MM109 knockout strain in which <italic>orf</italic> SLUN21380 was interrupted by a single-crossover event with insertion of a thiostreptone resistance cassette. A 791-bp internal fragment (starting at position nt +116&#x02009;and lacking the last 81 nt of SLUN21380) was amplified by PCR using primers <italic>fevR</italic>+118f_<italic>Xba</italic>I (TC<underline>TCTAGA</underline>CGAACCAGGTGGTCAGCC) and <italic>fevR</italic>+909r_<italic>Pst</italic>I (CG<underline>CTGCAG</underline>GTCGTTCTCCAGGCGC) (the underlined characters represent restriction sites). The PCR product was cloned into plasmid pJET1.2 (Blunt cloning vector; Thermo Fisher Scientific), and the product was named pBDF027 and sequenced for verification of the amplified PCR fragment. This plasmid was then digested by XbaI and PstI-HF restriction enzymes (NEB), and the <italic>fevR</italic> insertion was subsequently cloned into pSET151 (<xref rid="B41" ref-type="bibr">41</xref>) digested with the same enzymes. The plasmid resulting from the ligation, named pBDF028, was introduced into the <named-content content-type="genus-species">S. lunaelactis</named-content> MM109 chromosome by intergeneric conjugative transfer using methylation-deficient <named-content content-type="genus-species">Escherichia coli</named-content> ET12567 containing the plasmid pUZ8002 (ETpUZ) as conjugation partner. After growth of <named-content content-type="genus-species">E. coli</named-content> ETpUZ to an optical density (OD) of 0.4 (50&#x02009;ml of culture in a mixture of LB plus chloramphenicol [30&#x02009;&#x003bc;g/ml] plus kanamycin [50&#x02009;&#x003bc;g/ml] plus ampicillin [100&#x02009;&#x003bc;g/ml]), cells were washed to remove antibiotics and mixed with <named-content content-type="genus-species">S. lunaelactis</named-content> spores for mating. Selection of exconjugants was carried out on soy flour mannitol (SFM) medium (plus 10&#x02009;mM MgCl<sub>2</sub>) overlaid with thiostrepton (50&#x02009;&#x003bc;g/ml) and nalidixic acid (25&#x02009;&#x003bc;g/ml) after 16&#x02009;h of incubation at 28&#x000b0;C. The single-crossover insertion of pBDF028 into the <italic>fevR</italic> locus was confirmed by PCR, and one selected clone was named &#x003a9;<italic>fevR</italic> (MM109BD1) for further analyses.</p><p>To generate a <named-content content-type="genus-species">S. lunaelactis</named-content> strain overproducing FevR, an entire copy of <italic>fevR</italic> (slun21380) that included the 217-bp upstream and 360-bp downstream regions was amplified by PCR with primers BDF53 (GATCTAGAAAGCTTGGCTCTGTCCAGTGAGACATCC) and BDF54 (GCGAATTCGTACTCGATGTCACCCGCC) to obtain a 1,570-bp fragment flanked by EcoRI and XbaI restriction sites. The PCR product was first cloned into pJET1.2, and the product was named pBDF019. Using EcoRI-HF and XbaI enzymes, the 1,570-bp <italic>fevR</italic>-containing fragment was cloned into a pSET152 (<xref rid="B41" ref-type="bibr">41</xref>) integrative vector, producing pBDF021. Conjugation was performed with spores (10<sup>8</sup>) of <named-content content-type="genus-species">S. lunaelactis</named-content> MM109 on SFM (plus 10&#x02009;mM MgCl<sub>2</sub>) overlaid with apramycin and nalidixic acid. Integration of the plasmid was confirmed by PCR with pSET_forward (GAGCGGATAACAATTTCACACAGGA) and BDF53 or pSET_reverse (CGCCAGGGTTTTCCCAGTCACGAC) and BDF54 primers. The selected MM109<sup>T</sup> derivative with pBDF021 inserted to add an additional copy of <italic>slun21380</italic> (<italic>fevR</italic>) controlled by its native promoter was named MM109BD2 (<xref rid="tab2" ref-type="table">Table&#x000a0;2</xref>).</p><p>For complementation of the &#x003a9;<italic>fevR</italic> mutant (strain MM109BD1), an entire copy of <italic>fevR</italic> was excised from pBDF019 using EcoRI and XbaI restriction sites and cloned in the same sites of the intermediate-copy-number pHJL401 plasmid (&#x0223c;10 copies) was achieved by conjugation with plasmid pBDF029, leading to production of pBDF022. To include in pBDF022 the origin of transfer required for conjugation and a resistance marker for selection of exconjugants, the apramycin resistance cassette (from pIJ773) containing both <italic>oriT</italic> (RK2) and <italic>aac(3)IV</italic> (ApraR) was amplified by PCR with primers Apra_P1 (ATTCCGGGGATCCGTCGACC) and Apra_P2_HindIII (AAAAAGCTTTGTAGGCTGGAGCTGCTTC) and cloned in the same sites of pBDF022, resulting in plasmid pBDF029. Conjugation of pBDF29 into spores (10<sup>8</sup>) of <named-content content-type="genus-species">S. lunaelactis</named-content> MM109BD1 was performed as described above.</p></sec><sec id="s4.3"><title>Compound extraction and analysis by high-pressure liquid chromatography (HPLC).</title><p>Compound extraction and HPLC analysis were mainly performed as described previously (<xref rid="B26" ref-type="bibr">26</xref>). All <named-content content-type="genus-species">S. lunaelactis</named-content> strains were cultured for 10&#x02009;days on different solid media on petri dishes (90-mm diameter, 25&#x02009;ml of medium) and incubated at 28&#x000b0;C. The solid cultures were cut into small pieces (about 0.5&#x02009;by&#x02009;0.5&#x02009;cm) and then mixed overnight with an equal volume (25&#x02009;ml per plate) of ethyl acetate. The mixture was centrifuged (20&#x02009;min at 4,000&#x02009;rpm) and the supernatant was evaporated (25&#x000b0;C at 210&#x02009;rpm) on a rotary evaporator (IKA RV10 digital; VWR, Radnor, PA, USA). The dried crude extract was resuspended in 1&#x02009;ml of acetonitrile for further analyses. The full extract was then fractionated by HPLC (Waters, Milford, MA, USA) using a Waters 2695 Separations Module (Alliance) with a Waters 2998 photodiode array detector coupled to a Waters Fraction Collector (model WFC III). The extracts were analyzed on a Luna Omega PS C<sub>18</sub> column (Phenomenex) (2.1&#x02009;mm by 150&#x02009;mm, 5-&#x003bc;m particle size, 100-&#x000c5; pore size) at a column temperature of 40&#x000b0;C. Extract separation was achieved by increasing the ratio of acetonitrile (Barker; HPLC Far UV grade) to water (MilliQ filtration using a pore size of 0.22&#x02009;&#x003bc;m)&#x02013;0.05% trifluoroacetic acid (TFA) (Thermo Fisher Scientific, San Jose, CA, USA; sequencing grade) (from 0% to 100% acetonitrile during 80&#x02009;min) at a flow rate of 450&#x02009;&#x003bc;l/min. Online UV absorption measurement was performed from 190 to 800&#x02009;nm. Data were analyzed using Empower 3 software (Waters, Milford, MA, USA) and Xcalibur v2.2 software (Thermo Fisher Scientific, San Jose, CA, USA). Fractions were subsequently tested for antibacterial activities against <named-content content-type="genus-species">Staphylococcus aureus</named-content> (ATCC 25923) by disk diffusion assay as described previously (<xref rid="B26" ref-type="bibr">26</xref>).</p></sec><sec id="s4.4"><title>Compound identification by ultraperformance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS).</title><p>UV light-visible light absorbance spectra were obtained by analytical HPLC RP-C<sub>18</sub> analyses. High-resolution electrospray ionization mass spectrometry (HRESIMS) data were acquired on a Q Exactive Plus hybrid Quadrupole-Orbitrap mass spectrometer (Thermo Fisher Scientific, San Jose, CA, USA). Briefly, compounds were separated by reverse-phase chromatography using ultraperformance liquid chromatography (UPLC I-Class; Waters) and a Nucleodur C<sub>18ec</sub> column (Macherey-Nagel) (2.0&#x02009;mm by 150&#x02009;mm, 5-&#x003bc;m particle size). Elution was achieved by increasing the ratio of acetonitrile to water (MilliQ filtration using a pore size of 0.22&#x02009;&#x003bc;m)&#x02013;0.05% trifluoroacetic acid (for positive-ionization mode) (from 0% to 62.5% during 30&#x02009;min and then from 62.5% to 100% during 8&#x02009;min) at a flow rate of 300&#x02009;&#x003bc;l/min. For the negative-ionization mode, elution was achieved by increasing the ratio of acetonitrile to water (MilliQ filtration using a pore size of 0.22&#x02009;&#x003bc;m)&#x02013;0.1% formic acid (from 0% to 62.5% during 30&#x02009;min and then from 62.5% to 100% during 8&#x02009;min) at a flow rate of 300&#x02009;&#x003bc;l/min on a Luna Omega PS C<sub>18</sub> column (Phenomenex) (2.1&#x02009;mm by 150&#x02009;mm, 5-&#x003bc;m particle size, 100-&#x000c5; pore size). On-line UV absorption measurement was performed at 210 and 265&#x02009;nm, and the chromatography system was finally coupled to a Q Exactive Plus hybrid Quadrupole-Orbitrap mass spectrometer (Thermo Fisher Scientific, San Jose, CA, USA), operated in positive-ion mode (for bagremycins) and in negative mode (for ferroverdins and bagremycins), and programmed for data-dependent acquisitions. Survey scans were acquired at a mass-resolving power level of 140,000 FWHM (full width at half-maximum) and at 100 to 1,500&#x02009;<italic>m/z</italic> (accumulation target, 1&#x02009;&#x000d7;&#x02009;10<sup>6</sup> ion). The five ions showing the greatest intensity were then selected for tandem mass spectrometry (MS/MS) experiments by the use of higher-energy collision dissociation (HCD) fragmentations and stepped normalized collision energy (NCE) (21,2; 25; 28) within 2-atomic-mass-unit (amu) isolation windows (resolution, 17,500; accumulation target, 1&#x02009;&#x000d7;&#x02009;10<sup>5</sup> ions). Dynamic exclusion was enabled for 10&#x02009;s. Data were analyzed using Xcalibur v2.2 (Thermo Fisher Scientific, San Jose, CA, USA).</p><p>Each of the compounds was identified in accordance with its exact mass and isotope pattern, observation of the MS/MS spectra obtained by molecular ion fragmentation, and the UV-VIS absorbance spectra. For each molecule, a fragmentation pathway was proposed (see <xref ref-type="supplementary-material" rid="figS3">Fig.&#x000a0;S3</xref> in the supplemental material).</p><supplementary-material content-type="local-data" id="figS3"><object-id pub-id-type="doi">10.1128/mBio.01230-19.3</object-id><label>FIG&#x000a0;S3</label><p>ESI (negative)-MS/MS spectra and proposed fragmentation mechanisms for each deprotonated molecule identified in this study. Fragmentation mechanisms of ferroverdins (compounds 1, 2, and 3) were obtained by HCD fragmentation of molecular ions (M-) 860.12, 876.11, and 904.11, respectively. Fragmentation mechanism data from bagremycins (compounds 4, 5, 6, 7, 8, and 9) were obtained by HCD fragmentation of molecular ions (M-H)<sup>-</sup> 254.08, 269.09, 415.10, 239.07, 429.11, and 282.08, respectively. Download <inline-supplementary-material id="fS3" mimetype="application" mime-subtype="pdf" xlink:href="mBio.01230-19-sf003.pdf" content-type="local-data">FIG&#x000a0;S3, PDF file, 0.5 MB</inline-supplementary-material>.</p><permissions><copyright-statement>Copyright &#x000a9; 2019 Martinet et al.</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>Martinet et al.</copyright-holder><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/"><license-p>This content is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>.</license-p></license></permissions></supplementary-material></sec><sec id="s4.5"><title>Bioinformatics.</title><p>The complete genome sequence of the <named-content content-type="genus-species">S. lunaelactis</named-content> MM109<sup>T</sup> type strain was assembled from Illumina HiSeq and MiSeq short reads (Illumina, CA, USA) and Nanopore MinION long reads (Oxford Nanopore Technologies, United Kingdom) as described previously (<xref rid="B28" ref-type="bibr">28</xref>). Other <named-content content-type="genus-species">S. lunaelactis</named-content> strains genomes were assembled from Illumina reads only, using the complete genome sequence of the <named-content content-type="genus-species">S. lunaelactis</named-content> MM109<sup>T</sup> type strain as the template (<xref rid="B29" ref-type="bibr">29</xref>).</p><p>The sequencing was performed at the GIGA-Research Center (Li&#x000e8;ge University, Belgium) (HiSeq and MinION) and at the Luxembourg Institute of Science and Technology (Belvaux, Luxembourg) (MiSeq).</p><p>Phylogeny analyses were performed with sequences of homolog proteins from the <italic>fev</italic> (<named-content content-type="genus-species">S. lunaelactis</named-content> MM109, <italic>Streptomyces</italic> sp. WK-5344), <italic>bag</italic> (<italic>Streptomyces</italic> sp. T&#x000fc; 4128), <italic>gri</italic> (<italic>S. griseus</italic>), and <italic>nsp</italic> (<named-content content-type="genus-species">S. murayamaensis</named-content>) clusters. Proteins were aligned with MAFFT (v7.273, localpair mode), and alignments were trimmed and internal gaps removed. Phylogenetic inference was deduced using the maximum likelihood method as implemented in RAxML (v8.1.17, rapid bootstrapping mode with 1,000 replicates, GAMMA model of rate heterogeneity with WAG amino acid substitution matrix).</p></sec></sec></body><back><fn-group><fn fn-type="other"><p><bold>Citation</bold> Martinet L, Na&#x000f4;m&#x000e9; A, Deflandre B, Maciejewska M, Tellatin D, Tenconi E, Smargiasso N, de Pauw E, van Wezel GP, Rigali S. 2019. A single biosynthetic gene cluster is responsible for the production of bagremycin antibiotics and ferroverdin iron chelators. mBio 10:e01230-19. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/mBio.01230-19">https://doi.org/10.1128/mBio.01230-19</ext-link>.</p></fn></fn-group><ack><title>ACKNOWLEDGMENTS</title><p>The work performed by L.M. and M.M. was supported by a Research Foundation for Industry and Agriculture (FRIA) grant. The work performed by A.N. was supported by a First Spin-off grant from the Walloon region (grant 1510530; FSO AntiPred). S.R. is a Ma&#x000ee;tre de Recherche at the Belgian Fund for Scientific Research (F.R.S.-FNRS). G.P.V.W. acknowledges NACTAR grant 16439 from the Netherlands Organization for Scientific Research (NWO).</p><p>We declare that we have no conflicts of interest.</p></ack><ref-list><title>REFERENCES</title><ref id="B1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Davies</surname><given-names>J</given-names></name></person-group>
<year>2013</year>
<article-title>Specialized microbial metabolites: functions and origins</article-title>. <source>J Antibiot</source>
<volume>66</volume>:<fpage>361</fpage>&#x02013;<lpage>364</lpage>. doi:<pub-id pub-id-type="doi">10.1038/ja.2013.61</pub-id>.<pub-id pub-id-type="pmid">23756686</pub-id></mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Challis</surname><given-names>GL</given-names></name>, <name name-style="western"><surname>Hopwood</surname><given-names>DA</given-names></name></person-group>
<year>2003</year>
<article-title>Synergy and contingency as driving forces for the evolution of multiple secondary metabolite production by <italic>Streptomyces</italic> species</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>100</volume>:<fpage>14555</fpage>&#x02013;<lpage>14561</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.1934677100</pub-id>.<pub-id pub-id-type="pmid">12970466</pub-id></mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Loureiro</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Medema</surname><given-names>MH</given-names></name>, <name name-style="western"><surname>van der Oost</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Sipkema</surname><given-names>D</given-names></name></person-group>
<year>2018</year>
<article-title>Exploration and exploitation of the environment for novel specialized metabolites</article-title>. <source>Curr Opin Biotechnol</source>
<volume>50</volume>:<fpage>206</fpage>&#x02013;<lpage>213</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.copbio.2018.01.017</pub-id>.<pub-id pub-id-type="pmid">29454184</pub-id></mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Walsh</surname><given-names>CT</given-names></name>, <name name-style="western"><surname>Fischbach</surname><given-names>MA</given-names></name></person-group>
<year>2010</year>
<article-title>Natural Products Version 2.0: Connecting Genes to Molecules</article-title>. <source>J Am Chem Soc</source>
<volume>132</volume>:<fpage>2469</fpage>&#x02013;<lpage>2493</lpage>. doi:<pub-id pub-id-type="doi">10.1021/ja909118a</pub-id>.<pub-id pub-id-type="pmid">20121095</pub-id></mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Medema</surname><given-names>MH</given-names></name>, <name name-style="western"><surname>Kottmann</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Yilmaz</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Cummings</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Biggins</surname><given-names>JB</given-names></name>, <name name-style="western"><surname>Blin</surname><given-names>K</given-names></name>, <name name-style="western"><surname>de Bruijn</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Chooi</surname><given-names>YH</given-names></name>, <name name-style="western"><surname>Claesen</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Coates</surname><given-names>RC</given-names></name>, <name name-style="western"><surname>Cruz-Morales</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Duddela</surname><given-names>S</given-names></name>, <name name-style="western"><surname>D&#x000fc;sterhus</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Edwards</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Fewer</surname><given-names>DP</given-names></name>, <name name-style="western"><surname>Garg</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Geiger</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Gomez-Escribano</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Greule</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Hadjithomas</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Haines</surname><given-names>AS</given-names></name>, <name name-style="western"><surname>Helfrich</surname><given-names>EJN</given-names></name>, <name name-style="western"><surname>Hillwig</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Ishida</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Jones</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Jones</surname><given-names>CS</given-names></name>, <name name-style="western"><surname>Jungmann</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Kegler</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>HU</given-names></name>, <name name-style="western"><surname>K&#x000f6;tter</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Krug</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Masschelein</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Melnik</surname><given-names>AV</given-names></name>, <name name-style="western"><surname>Mantovani</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Monroe</surname><given-names>EA</given-names></name>, <name name-style="western"><surname>Moore</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Moss</surname><given-names>N</given-names></name>, <name name-style="western"><surname>N&#x000fc;tzmann</surname><given-names>H-W</given-names></name>, <name name-style="western"><surname>Pan</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Pati</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Petras</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Reen</surname><given-names>FJ</given-names></name>, <name name-style="western"><surname>Rosconi</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Rui</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Tian</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Tobias</surname><given-names>NJ</given-names></name>, <name name-style="western"><surname>Tsunematsu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Wiemann</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Wyckoff</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Yan</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Yim</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Xie</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Aigle</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Apel</surname><given-names>AK</given-names></name>, <name name-style="western"><surname>Balibar</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Balskus</surname><given-names>EP</given-names></name>, <name name-style="western"><surname>Barona-G&#x000f3;mez</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Bechthold</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Bode</surname><given-names>HB</given-names></name>, <name name-style="western"><surname>Borriss</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Brady</surname><given-names>SF</given-names></name>, <name name-style="western"><surname>Brakhage</surname><given-names>AA</given-names></name>, <name name-style="western"><surname>Caffrey</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Cheng</surname><given-names>Y-Q</given-names></name>, <name name-style="western"><surname>Clardy</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Cox</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>De Mot</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Donadio</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Donia</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>van der Donk</surname><given-names>WA</given-names></name>, <name name-style="western"><surname>Dorrestein</surname><given-names>PC</given-names></name>, <name name-style="western"><surname>Doyle</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Driessen</surname><given-names>AJM</given-names></name>, <name name-style="western"><surname>Ehling-Schulz</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Entian</surname><given-names>K-D</given-names></name>, <name name-style="western"><surname>Fischbach</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Gerwick</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Gerwick</surname><given-names>WH</given-names></name>, <name name-style="western"><surname>Gross</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Gust</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Hertweck</surname><given-names>C</given-names></name>, <name name-style="western"><surname>H&#x000f6;fte</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Jensen</surname><given-names>SE</given-names></name>, <name name-style="western"><surname>Ju</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Katz</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Kaysser</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Klassen</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Keller</surname><given-names>NP</given-names></name>, <name name-style="western"><surname>Kormanec</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Kuipers</surname><given-names>OP</given-names></name>, <name name-style="western"><surname>Kuzuyama</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Kyrpides</surname><given-names>NC</given-names></name>, <name name-style="western"><surname>Kwon</surname><given-names>H-J</given-names></name>, <name name-style="western"><surname>Lautru</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Lavigne</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>CY</given-names></name>, <name name-style="western"><surname>Linquan</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Luzhetskyy</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Mahmud</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Mast</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>M&#x000e9;ndez</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Mets&#x000e4;-Ketel&#x000e4;</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Micklefield</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Mitchell</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Moore</surname><given-names>BS</given-names></name>, <name name-style="western"><surname>Moreira</surname><given-names>LM</given-names></name>, <name name-style="western"><surname>M&#x000fc;ller</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Neilan</surname><given-names>BA</given-names></name>, <name name-style="western"><surname>Nett</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Nielsen</surname><given-names>J</given-names></name>, <name name-style="western"><surname>O'Gara</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Oikawa</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Osbourn</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Osburne</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Ostash</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Payne</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Pernodet</surname><given-names>J-L</given-names></name>, <name name-style="western"><surname>Petricek</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Piel</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Ploux</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Raaijmakers</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Salas</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Schmitt</surname><given-names>EK</given-names></name>, <name name-style="western"><surname>Scott</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Seipke</surname><given-names>RF</given-names></name>, <name name-style="western"><surname>Shen</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Sherman</surname><given-names>DH</given-names></name>, <name name-style="western"><surname>Sivonen</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Smanski</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Sosio</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Stegmann</surname><given-names>E</given-names></name>, <name name-style="western"><surname>S&#x000fc;ssmuth</surname><given-names>RD</given-names></name>, <name name-style="western"><surname>Tahlan</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Thomas</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Tang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Truman</surname><given-names>AW</given-names></name>, <name name-style="western"><surname>Viaud</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Walton</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Walsh</surname><given-names>CT</given-names></name>, <name name-style="western"><surname>Weber</surname><given-names>T</given-names></name>, <name name-style="western"><surname>van Wezel</surname><given-names>GP</given-names></name>, <name name-style="western"><surname>Wilkinson</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Willey</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Wohlleben</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Wright</surname><given-names>GD</given-names></name>, <name name-style="western"><surname>Ziemert</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Zotchev</surname><given-names>SB</given-names></name>, <name name-style="western"><surname>Breitling</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Takano</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Gl&#x000f6;ckner</surname><given-names>FO</given-names></name></person-group>
<year>2015</year>
<article-title>Minimum Information about a Biosynthetic Gene cluster</article-title>. <source>Nat Chem Biol</source>
<volume>11</volume>:<fpage>625</fpage>&#x02013;<lpage>631</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nchembio.1890</pub-id>.<pub-id pub-id-type="pmid">26284661</pub-id></mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tenconi</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Rigali</surname><given-names>S</given-names></name></person-group>
<year>2018</year>
<article-title>Self-resistance mechanisms to DNA-damaging antitumor antibiotics in Actinobacteria</article-title>. <source>Curr Opin Microbiol</source>
<volume>45</volume>:<fpage>100</fpage>&#x02013;<lpage>108</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.mib.2018.03.003</pub-id>.<pub-id pub-id-type="pmid">29642052</pub-id></mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van der Heul</surname><given-names>HU</given-names></name>, <name name-style="western"><surname>Bilyk</surname><given-names>BL</given-names></name>, <name name-style="western"><surname>McDowall</surname><given-names>KJ</given-names></name>, <name name-style="western"><surname>Seipke</surname><given-names>RF</given-names></name>, <name name-style="western"><surname>van Wezel</surname><given-names>GP</given-names></name></person-group>
<year>2018</year>
<article-title>Regulation of antibiotic production in Actinobacteria: new perspectives from the post-genomic era</article-title>. <source>Nat Prod Rep</source>
<volume>35</volume>:<fpage>575</fpage>&#x02013;<lpage>604</lpage>. doi:<pub-id pub-id-type="doi">10.1039/C8NP00012C</pub-id>.<pub-id pub-id-type="pmid">29721572</pub-id></mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rigali</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Anderssen</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Na&#x000f4;m&#x000e9;</surname><given-names>A</given-names></name>, <name name-style="western"><surname>van Wezel</surname><given-names>GP</given-names></name></person-group>
<year>2018</year>
<article-title>Cracking the regulatory code of biosynthetic gene clusters as a strategy for natural product discovery</article-title>. <source>Biochem Pharmacol</source>
<volume>153</volume>:<fpage>24</fpage>&#x02013;<lpage>34</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bcp.2018.01.007</pub-id>.<pub-id pub-id-type="pmid">29309762</pub-id></mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rutledge</surname><given-names>PJ</given-names></name>, <name name-style="western"><surname>Challis</surname><given-names>GL</given-names></name></person-group>
<year>2015</year>
<article-title>Discovery of microbial natural products by activation of silent biosynthetic gene clusters</article-title>. <source>Nat Rev Microbiol</source>
<volume>13</volume>:<fpage>509</fpage>&#x02013;<lpage>523</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nrmicro3496</pub-id>.<pub-id pub-id-type="pmid">26119570</pub-id></mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kolter</surname><given-names>R</given-names></name>, <name name-style="western"><surname>van Wezel</surname><given-names>GP</given-names></name></person-group>
<year>2016</year>
<article-title>Goodbye to brute force in antibiotic discovery?</article-title>
<source>Nat Microbiol</source>
<volume>1</volume>:<fpage>15020</fpage>. doi:<pub-id pub-id-type="doi">10.1038/nmicrobiol.2015.20</pub-id>.<pub-id pub-id-type="pmid">27571977</pub-id></mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Medema</surname><given-names>MH</given-names></name>, <name name-style="western"><surname>L&#x000e4;kamp</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Dorrestein</surname><given-names>PC</given-names></name>, <name name-style="western"><surname>Choi</surname><given-names>YH</given-names></name>, <name name-style="western"><surname>van Wezel</surname><given-names>GP</given-names></name></person-group>
<year>2016</year>
<article-title>Leucanicidin and Endophenasides Result from Methyl-Rhamnosylation by the Same Tailoring Enzymes in <italic>Kitasatospora</italic> sp. MBT66</article-title>. <source>ACS Chem Biol</source>
<volume>11</volume>:<fpage>478</fpage>&#x02013;<lpage>490</lpage>. doi:<pub-id pub-id-type="doi">10.1021/acschembio.5b00801</pub-id>.<pub-id pub-id-type="pmid">26675041</pub-id></mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Traxler</surname><given-names>MF</given-names></name>, <name name-style="western"><surname>Watrous</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Alexandrov</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Dorrestein</surname><given-names>PC</given-names></name>, <name name-style="western"><surname>Kolter</surname><given-names>R</given-names></name></person-group>
<year>2013</year>
<article-title>Interspecies Interactions Stimulate Diversification of the <italic>Streptomyces coelicolor</italic> Secreted Metabolome</article-title>. <source>mBio</source>
<volume>4</volume>doi:<pub-id pub-id-type="doi">10.1128/mBio.00459-13</pub-id>.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fischbach</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Clardy</surname><given-names>J</given-names></name></person-group>
<year>2007</year>
<article-title>One pathway, many products</article-title>. <source>Nat Chem Biol</source>
<volume>3</volume>:<fpage>353</fpage>&#x02013;<lpage>355</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nchembio0707-353</pub-id>.<pub-id pub-id-type="pmid">17576415</pub-id></mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Gui</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Ju</surname><given-names>J</given-names></name></person-group>
<year>2018</year>
<article-title>Biosynthetic Baeyer&#x02013;Villiger Chemistry Enables Access to Two Anthracene Scaffolds from a Single Gene Cluster in Deep-Sea-Derived <italic>Streptomyces olivaceus</italic> SCSIO T05</article-title>. <source>J Nat Prod</source>
<volume>81</volume>:<fpage>1570</fpage>&#x02013;<lpage>1577</lpage>. doi:<pub-id pub-id-type="doi">10.1021/acs.jnatprod.8b00077</pub-id>.<pub-id pub-id-type="pmid">30015485</pub-id></mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yin</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Yan</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Lohman</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>S-X</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>G-R</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>L-H</given-names></name>, <name name-style="western"><surname>Xiang</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Shen</surname><given-names>B</given-names></name></person-group>
<year>2014</year>
<article-title>Cycloheximide and Actiphenol Production in <italic>Streptomyces</italic> sp. YIM56141 Governed by Single Biosynthetic Machinery Featuring an Acyltransferase-less Type I Polyketide Synthase</article-title>. <source>Org Lett</source>
<volume>16</volume>:<fpage>3072</fpage>&#x02013;<lpage>3075</lpage>. doi:<pub-id pub-id-type="doi">10.1021/ol501179w</pub-id>.<pub-id pub-id-type="pmid">24815182</pub-id></mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gubbens</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Filippov</surname><given-names>DV</given-names></name>, <name name-style="western"><surname>Florea</surname><given-names>BI</given-names></name>, <name name-style="western"><surname>Rigali</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Overkleeft</surname><given-names>HS</given-names></name>, <name name-style="western"><surname>van Wezel</surname><given-names>GP</given-names></name></person-group>
<year>2017</year>
<article-title>Intertwined Precursor Supply during Biosynthesis of the Catecholate&#x02013;Hydroxamate Siderophores Qinichelins in <italic>Streptomyces</italic> sp. MBT76</article-title>. <source>ACS Chem Biol</source>
<volume>12</volume>:<fpage>2756</fpage>&#x02013;<lpage>2766</lpage>. doi:<pub-id pub-id-type="doi">10.1021/acschembio.7b00597</pub-id>.<pub-id pub-id-type="pmid">28945067</pub-id></mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mast</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Weber</surname><given-names>T</given-names></name>, <name name-style="western"><surname>G&#x000f6;lz</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ort-Winklbauer</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Gondran</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Wohlleben</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Schinko</surname><given-names>E</given-names></name></person-group>
<year>2011</year>
<article-title>Characterization of the &#x02018;pristinamycin supercluster&#x02019; of <italic>Streptomyces pristinaespiralis</italic></article-title>. <source>Microb Biotechnol</source>
<volume>4</volume>:<fpage>192</fpage>&#x02013;<lpage>206</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1751-7915.2010.00213.x</pub-id>.<pub-id pub-id-type="pmid">21342465</pub-id></mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Candeloro</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Grdenic</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Taylor</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Thompson</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Viswamitra</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Hodgkin</surname><given-names>DC</given-names></name></person-group>
<year>1969</year>
<article-title>Structure of ferroverdin</article-title>. <source>Nature</source>
<volume>224</volume>:<fpage>589</fpage>&#x02013;<lpage>591</lpage>. doi:<pub-id pub-id-type="doi">10.1038/224589a0</pub-id>.<pub-id pub-id-type="pmid">5346597</pub-id></mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ballio</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Bertholdt</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Chain</surname><given-names>EB</given-names></name>, <name name-style="western"><surname>Di Vittorio</surname><given-names>V</given-names></name></person-group>
<year>1962</year>
<article-title>Structure of ferroverdin</article-title>. <source>Nature</source>
<volume>194</volume>:<fpage>769</fpage>&#x02013;<lpage>770</lpage>. doi:<pub-id pub-id-type="doi">10.1038/194769b0</pub-id>.<pub-id pub-id-type="pmid">13864452</pub-id></mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chain</surname><given-names>EB</given-names></name>, <name name-style="western"><surname>Tonolo</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Carilli</surname><given-names>A</given-names></name></person-group>
<year>1955</year>
<article-title>Ferroverdin, a green pigment containing iron produced by a streptomycete</article-title>. <source>Nature</source>
<volume>176</volume>:<fpage>645</fpage>. doi:<pub-id pub-id-type="doi">10.1038/176645a0</pub-id>.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tabata</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Tomoda</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Omura</surname><given-names>S</given-names></name></person-group>
<year>1999</year>
<article-title>Ferroverdins, inhibitors of cholesteryl ester transfer protein produced by <italic>Streptomyces</italic> sp. WK-5344. II. Structure elucidation</article-title>. <source>J Antibiot (Tokyo)</source>
<volume>52</volume>:<fpage>1108</fpage>&#x02013;<lpage>1113</lpage>. doi:<pub-id pub-id-type="doi">10.7164/antibiotics.52.1108</pub-id>.<pub-id pub-id-type="pmid">10695674</pub-id></mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bertasso</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Holzenk&#x000e4;mpfer</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Zeeck</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Dall'Antonia</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Fiedler</surname><given-names>HP</given-names></name></person-group>
<year>2001</year>
<article-title>Bagremycin A and B, novel antibiotics from <italic>Streptomyces</italic> sp. T&#x000fc; 4128</article-title>. <source>J Antibiot (Tokyo)</source>
<volume>54</volume>:<fpage>730</fpage>&#x02013;<lpage>736</lpage>. doi:<pub-id pub-id-type="doi">10.7164/antibiotics.54.730</pub-id>.<pub-id pub-id-type="pmid">11714229</pub-id></mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Chai</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Song</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Lian</surname><given-names>X-Y</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Z</given-names></name></person-group>
<year>2017</year>
<article-title>Cytotoxic Bagremycins from Mangrove-Derived <italic>Streptomyces</italic> sp. Q22</article-title>. <source>J Nat Prod</source>
<volume>80</volume>:<fpage>1450</fpage>&#x02013;<lpage>1456</lpage>. doi:<pub-id pub-id-type="doi">10.1021/acs.jnatprod.6b01136</pub-id>.<pub-id pub-id-type="pmid">28504888</pub-id></mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Shu</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Lian</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Z</given-names></name></person-group>
<year>2018</year>
<article-title>New Antibacterial Bagremycins F and G from the Marine-Derived <italic>Streptomyces</italic> sp. ZZ745</article-title>. <source>Mar Drugs</source>
<volume>16</volume>doi:<pub-id pub-id-type="doi">10.3390/md16090330</pub-id>.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maciejewska</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Pessi</surname><given-names>IS</given-names></name>, <name name-style="western"><surname>Arguelles-Arias</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Noirfalise</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Luis</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Ongena</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Barton</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Carnol</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Rigali</surname><given-names>S</given-names></name></person-group>
<year>2015</year>
<article-title><italic>Streptomyces lunaelactis</italic> sp. nov., a novel ferroverdin A-producing <italic>Streptomyces</italic> species isolated from a moonmilk speleothem</article-title>. <source>Antonie Van Leeuwenhoek</source>
<volume>107</volume>:<fpage>519</fpage>&#x02013;<lpage>531</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s10482-014-0348-4</pub-id>.<pub-id pub-id-type="pmid">25491121</pub-id></mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maciejewska</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Adam</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Martinet</surname><given-names>L</given-names></name></person-group>, <year>2016</year>
<article-title>A Phenotypic and Genotypic Analysis of the Antimicrobial Potential of Cultivable <italic>Streptomyces</italic> Isolated from Cave Moonmilk Deposits</article-title>. <source>Front Microbiol</source>
<volume>7</volume><etal/> doi:<pub-id pub-id-type="doi">10.3389/fmicb.2016.01455</pub-id>.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Adam</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Maciejewska</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Na&#x000f4;m&#x000e9;</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Martinet</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Coppieters</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Karim</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Baurain</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Rigali</surname><given-names>S</given-names></name></person-group>
<year>2018</year>
<article-title>Isolation, Characterization, and Antibacterial Activity of Hard-to-Culture Actinobacteria from Cave Moonmilk Deposits</article-title>. <source>Antibiotics</source>
<volume>7</volume>:<fpage>28</fpage>. doi:<pub-id pub-id-type="doi">10.3390/antibiotics7020028</pub-id>.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Na&#x000f4;m&#x000e9;</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Maciejewska</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Calusinska</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Martinet</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Anderssen</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Adam</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Tenconi</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Deflandre</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Coppieters</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Karim</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Hanikenne</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Baurain</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Delfosse</surname><given-names>P</given-names></name>, <name name-style="western"><surname>van Wezel</surname><given-names>GP</given-names></name>, <name name-style="western"><surname>Rigali</surname><given-names>S</given-names></name></person-group>
<year>2018</year>
<article-title>Complete Genome Sequence of <italic>Streptomyces lunaelactis</italic> MM109T, Isolated from Cave Moonmilk Deposits</article-title>. <source>Genome Announc</source>
<volume>6</volume>doi:<pub-id pub-id-type="doi">10.1128/genomeA.00435-18</pub-id>.</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Blin</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Wolf</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Chevrette</surname><given-names>MG</given-names></name></person-group>, <year>2017</year>
<article-title>antiSMASH 4.0-improvements in chemistry prediction and gene cluster boundary identification</article-title>. <source>Nucleic Acids Res</source><etal/> doi:<pub-id pub-id-type="doi">10.1093/nar/gkx319</pub-id>.</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Liao</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Ye</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name></person-group>
<year>2012</year>
<article-title>Cloning and characterization of a novel tyrosine ammonia lyase-encoding gene involved in bagremycins biosynthesis in <italic>Streptomyces</italic> sp</article-title>. <source>Biotechnol Lett</source>
<volume>34</volume>:<fpage>269</fpage>&#x02013;<lpage>274</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s10529-011-0755-9</pub-id>.<pub-id pub-id-type="pmid">22065278</pub-id></mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ye</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Hou</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name></person-group>
<year>2019</year>
<article-title>Characterization of the bagremycin biosynthetic gene cluster in <italic>Streptomyces</italic> sp. T&#x000fc; 4128</article-title>. <source>Biosci Biotechnol Biochem</source>
<volume>83</volume>:<fpage>482</fpage>&#x02013;<lpage>489</lpage>. doi:<pub-id pub-id-type="doi">10.1080/09168451.2018.1553605</pub-id>.<pub-id pub-id-type="pmid">30526412</pub-id></mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Noguchi</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Kitamura</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Onaka</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Horinouchi</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Ohnishi</surname><given-names>Y</given-names></name></person-group>
<year>2010</year>
<article-title>A copper-containing oxidase catalyzes C-nitrosation in nitrosobenzamide biosynthesis</article-title>. <source>Nat Chem Biol</source>
<volume>6</volume>:<fpage>641</fpage>&#x02013;<lpage>643</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nchembio.418</pub-id>.<pub-id pub-id-type="pmid">20676084</pub-id></mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Higashi</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Iwasaki</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Ohnishi</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Horinouchi</surname><given-names>S</given-names></name></person-group>
<year>2007</year>
<article-title>A-Factor and Phosphate Depletion Signals Are Transmitted to the Grixazone Biosynthesis Genes via the Pathway-Specific Transcriptional Activator GriR</article-title>. <source>J Bacteriol</source>
<volume>189</volume>:<fpage>3515</fpage>&#x02013;<lpage>3524</lpage>. doi:<pub-id pub-id-type="doi">10.1128/JB.00055-07</pub-id>.<pub-id pub-id-type="pmid">17337580</pub-id></mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Ye</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name></person-group>
<year>2015</year>
<article-title>Identification of BagI as a positive transcriptional regulator of bagremycin biosynthesis in engineered <italic>Streptomyces</italic> sp. T&#x000fc; 4128</article-title>. <source>Microbiol Res</source>
<volume>173</volume>:<fpage>18</fpage>&#x02013;<lpage>24</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.micres.2015.01.011</pub-id>.<pub-id pub-id-type="pmid">25801967</pub-id></mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marshall</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Payne</surname><given-names>KAP</given-names></name>, <name name-style="western"><surname>Leys</surname><given-names>D</given-names></name></person-group>
<year>2017</year>
<article-title>The UbiX-UbiD system: The biosynthesis and use of prenylated flavin (prFMN)</article-title>. <source>Arch Biochem Biophys</source>
<volume>632</volume>:<fpage>209</fpage>&#x02013;<lpage>221</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.abb.2017.07.014</pub-id>.<pub-id pub-id-type="pmid">28754323</pub-id></mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ginsbach</surname><given-names>JW</given-names></name>, <name name-style="western"><surname>Kieber-Emmons</surname><given-names>MT</given-names></name>, <name name-style="western"><surname>Nomoto</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Noguchi</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Ohnishi</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Solomon</surname><given-names>EI</given-names></name></person-group>
<year>2012</year>
<article-title>Structure/function correlations among coupled binuclear copper proteins through spectroscopic and reactivity studies of NspF</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>109</volume>:<fpage>10793</fpage>&#x02013;<lpage>10797</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.1208718109</pub-id>.<pub-id pub-id-type="pmid">22711806</pub-id></mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Suzuki</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Furusho</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Higashi</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Ohnishi</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Horinouchi</surname><given-names>S</given-names></name></person-group>
<year>2006</year>
<article-title>A Novel o-Aminophenol Oxidase Responsible for Formation of the Phenoxazinone Chromophore of Grixazone</article-title>. <source>J Biol Chem</source>
<volume>281</volume>:<fpage>824</fpage>&#x02013;<lpage>833</lpage>. doi:<pub-id pub-id-type="doi">10.1074/jbc.M505806200</pub-id>.<pub-id pub-id-type="pmid">16282322</pub-id></mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arias</surname><given-names>AA</given-names></name>, <name name-style="western"><surname>Lambert</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Martinet</surname><given-names>L</given-names></name></person-group>, <year>2015</year>
<article-title>Growth of desferrioxamine-deficient <italic>Streptomyces</italic> mutants through xenosiderophore piracy of airborne fungal contaminations</article-title>. <source>FEMS Microbiol Ecol</source>
<volume>91</volume><etal/> doi:<pub-id pub-id-type="doi">10.1093/femsec/fiv080</pub-id>.</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yamanaka</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Oikawa</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Ogawa</surname><given-names>H</given-names></name></person-group>, <year>2005</year>
<article-title>Desferrioxamine E produced by <italic>Streptomyces griseus</italic> stimulates growth and development of <italic>Streptomyces tanashiensis</italic></article-title>. <source>Microbiol Read Engl</source>
<volume>151</volume>:<fpage>2899</fpage>&#x02013;<lpage>2905</lpage><etal/> doi:<pub-id pub-id-type="doi">10.1099/mic.0.28139-0</pub-id>.</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lambert</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Traxler</surname><given-names>MF</given-names></name>, <name name-style="western"><surname>Craig</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Maciejewska</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ongena</surname><given-names>M</given-names></name>, <name name-style="western"><surname>van Wezel</surname><given-names>GP</given-names></name>, <name name-style="western"><surname>Kolter</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Rigali</surname><given-names>S</given-names></name></person-group>
<year>2014</year>
<article-title>Altered desferrioxamine-mediated iron utilization is a common trait of bald mutants of <italic>Streptomyces coelicolor</italic></article-title>. <source>Met Integr Biometal Sci</source>
<volume>6</volume>:<fpage>1390</fpage>&#x02013;<lpage>1399</lpage>. doi:<pub-id pub-id-type="doi">10.1039/C4MT00068D</pub-id>.</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation publication-type="other"><person-group person-group-type="author"><name name-style="western"><surname>Kieser</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Bibb</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Buttner</surname><given-names>MJ</given-names></name></person-group><etal/>
<year>2000</year>
<article-title>Practical <italic>Streptomyces</italic> Genetics</article-title>.</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bierman</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Logan</surname><given-names>R</given-names></name>, <name name-style="western"><surname>O'Brien</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Seno</surname><given-names>ET</given-names></name>, <name name-style="western"><surname>Nagaraja Rao</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Schoner</surname><given-names>BE</given-names></name></person-group>
<year>1992</year>
<article-title>Plasmid cloning vectors for the conjugal transfer of DNA from <italic>Escherichia coli</italic> to <italic>Streptomyces</italic> spp</article-title>. <source>Gene</source>
<volume>116</volume>:<fpage>43</fpage>&#x02013;<lpage>49</lpage>. doi:<pub-id pub-id-type="doi">10.1016/0378-1119(92)90627-2</pub-id>.<pub-id pub-id-type="pmid">1628843</pub-id></mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hillemann</surname><given-names>D</given-names></name>, <name name-style="western"><surname>P&#x000fc;hler</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Wohlleben</surname><given-names>W</given-names></name></person-group>
<year>1991</year>
<article-title>Gene disruption and gene replacement in <italic>Streptomyces</italic> via single stranded DNA transformation of integration vectors</article-title>. <source>Nucleic Acids Res</source>
<volume>19</volume>:<fpage>727</fpage>&#x02013;<lpage>731</lpage>. doi:<pub-id pub-id-type="doi">10.1093/nar/19.4.727</pub-id>.<pub-id pub-id-type="pmid">2017360</pub-id></mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bignell</surname><given-names>DRD</given-names></name>, <name name-style="western"><surname>Tahlan</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Colvin</surname><given-names>KR</given-names></name>, <name name-style="western"><surname>Jensen</surname><given-names>SE</given-names></name>, <name name-style="western"><surname>Leskiw</surname><given-names>BK</given-names></name></person-group>
<year>2005</year>
<article-title>Expression of <italic>ccaR</italic>, encoding the positive activator of cephamycin C and clavulanic acid production in <italic>Streptomyces clavuligerus</italic>, is dependent on <italic>bldG</italic></article-title>. <source>Antimicrob Agents Chemother</source>
<volume>49</volume>:<fpage>1529</fpage>&#x02013;<lpage>1541</lpage>. doi:<pub-id pub-id-type="doi">10.1128/AAC.49.4.1529-1541.2005</pub-id>.<pub-id pub-id-type="pmid">15793135</pub-id></mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gust</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Challis</surname><given-names>GL</given-names></name>, <name name-style="western"><surname>Fowler</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Kieser</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Chater</surname><given-names>KF</given-names></name></person-group>
<year>2003</year>
<article-title>PCR-targeted <italic>Streptomyces</italic> gene replacement identifies a protein domain needed for biosynthesis of the sesquiterpene soil odor geosmin</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>100</volume>:<fpage>1541</fpage>&#x02013;<lpage>1546</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.0337542100</pub-id>.<pub-id pub-id-type="pmid">12563033</pub-id></mixed-citation></ref></ref-list></back></article>